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As forensic DNA analysis has experienced countless advances in the past several 
decades, it has gained considerable notoriety among the general public, including those that are 
involved in the commission of crimes, leading to biological evidence that has been contaminated 
with various cleaning products in an attempt to conceal or destroy DNA evidence. This research 
examined the effects that three types of cleaning agents have on the ability of the Applied 
Biosystems® Automate Express™ Forensic DNA Extraction System to efficiently extract high 
quality DNA free from inhibiting compounds using the Prepfiler Express™ Forensic DNA 
Extraction Kit. This study further assessed the impact that these chemicals have on the entire 
forensic DNA analysis process through evaluation of the quality of genetic profiles using a 
quantitative scale. A dilution series (neat to 1:1000) was prepared from whole human blood, as 
well as from a bleach product containing sodium hydroxide, a quaternary ammonium-based 
multi-surface cleaner, and a carpet cleaner with hydrogen peroxide as the active ingredient. Each 
blood dilution was combined with each dilution of the three cleaning products and each of those 
samples was analyzed in triplicate. The amount of DNA extracted from bleach-treated samples 
was reduced compared to corresponding control samples due to destruction of the DNA prior to 
extraction. The quantification results from samples treated with both the ammonium-based 
cleaner and the hydrogen peroxide carpet cleaner were similar to controls. The automated system 
successfully removed inhibitory compounds from samples containing sodium hydroxide and 
quaternary ammonium compounds, but the blood samples containing the concentrated hydrogen 
peroxide cleaner showed increased inhibition. The genetic profile quality scores indicated that 
the ammonium-based cleaner had no effect on profiles regardless of the dilution ratio of the 
sample, while samples containing at least equal amounts of bleach and blood can be expected to 




display extensive dropout of alleles. The inhibition previously mentioned due to the hydrogen 
peroxide carpet cleaner completely inhibited amplification in samples containing 1:100 or 
1:1000 diluted blood treated with neat carpet cleaner. These results indicate that crime scene 
personnel should document any cleaning agents that may have contaminated biological evidence 
as it could significantly impact the results of DNA analysis depending on the type of product and 
its concentration in relation to the evidence. 
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 One of the most crucial and commonly encountered types of evidence during the forensic 
investigation of crimes is blood. The presence of blood can be an indicator of violence inflicted 
on one person by another, while the genetic information contained within the cells of blood can 
provide evidence to investigators that a suspect or victim may have been in a specific location or 
come in contact with a specific object. Since blood evidence can provide such probative 
information, criminals often go to great lengths to prevent its detection. Historical records have 
described the use of chemical tests to detect latent blood evidence in forensic investigations 
dating back to 1440 A.D. (Nam, Won, & Lee, 2014). More recently, with knowledge about the 
capabilities of forensic DNA testing becoming more widespread, criminals not only wish to 
conceal bloodstains, but also seek to destroy the identifying biological information found in 
blood evidence. Typically, the concealment of bloodstains is attempted through the use of 
commercially available cleaning solutions in an effort to remove any visible traces of blood. 
Utilizing these cleaning solutions leads to potentially compromised forensic samples that contain 
foreign chemical agents, often in significantly higher volumes than the blood itself. As forensic 
DNA technologies and methods continue to develop, research is necessary to investigate the 
effects these chemicals have at various stages in the DNA analysis process. 
1.1 Automated DNA Extraction Technology 
 
  When analyzing DNA present in evidentiary blood samples, the first step in the process is 
the extraction of genetic material from white blood cells within the blood and the removal of 
contaminants and other cellular components (Li, 2008). Currently, more and more forensic 
biology labs are employing automated extraction systems to accomplish this. There are various 




systems available that employ different extraction kits and methods of binding and purifying 
DNA. All of the systems have reduced the time and labor required for this portion of DNA 
analysis while providing more consistent processing of many types of samples (Rechsteiner, 
2006). One such system is the Automate Express™ Forensic DNA Extraction System which uses 
the PrepFiler Express™ Forensic DNA Extraction Kit to extract and purify DNA from a variety 
of forensic samples using paramagnetic particles. After the cells in a sample have been lysed to 
release the cellular DNA into solution, the system uses a multi-component surface chemistry to 
first bind the DNA to the paramagnetic resin, then to hold the bound DNA stationary throughout 
a series of washes using magnets, before finally eluting the purified DNA free from extraneous 
substances. (Brevnov, Pawar, Mundt, Calandro, Furtado, & Shewale, 2009) Because the system 
operates using a series of specific chemical interactions between the sample lysate, resin, and 
buffers, the presence of a contaminating chemical substance within a sample that alters those 
reactions could be detrimental to the system’s performance.  
1.2 Characteristics of Three Common Types of Cleaning Agents 
 
 Some of the most common chemical substances that may be present in samples of blood 
collected from crime scenes are those found in commercial cleaning products due to the 
attempted concealment of this evidence by those involved in the crime. Three common classes of 
products that might be used to destroy evidence of a crime are bleach solutions containing 
sodium hypochlorite, liquid disinfectant products that contain quaternary ammonium 
compounds, and “stain-fighting” cleaners that have an active ingredient of hydrogen peroxide. 
 Bleach solutions containing sodium hypochlorite are alkaline solutions with a highly 
basic pH, usually between 11and 12 for Clorox® brand solutions (The Clorox Company), that 




have been studied for many years for their cytotoxic effects on bacteria. Studies have shown that 
sodium hypochlorite destroys these organisms by penetrating the cell’s nucleus and damaging 
the DNA directly (Rosenkranz, 1973). This property has led to the use of sodium hypochlorite 
solutions for the decontamination of surfaces and equipment in forensic laboratories 
(Vandewoestyne, et al., 2011) and for the removal of extraneous DNA from the surfaces of 
forensic bone and tooth samples (Kemp & Smith, 2005). Due to its ability to induce significant 
damage to the DNA molecule, the presence of chemical solutions containing sodium 
hypochlorite in a forensic blood sample could have serious, detrimental effects on the ability to 
generate a viable genetic profile. These effects need to be quantified in a way that allows for a 
more accurate understanding of the limitations of current DNA technology. 
 Quaternary ammonium compounds, or QACs, are the active ingredient in various 
cleaning products including liquid surface disinfectants. The antimicrobial properties of QACs 
are due to their interaction with, and eventual destruction of, the lipid membranes of bacterial 
cells (McDonnell & Russell, 1999). Destruction of these membranes leads to leakage of cellular 
contents and degradation of nuclear DNA (Salton, 1968). QACs have also been shown to directly 
damage DNA in the form of lesions and strand breaks in both bacterial (Deutschle, Porkert, 
Reiter, Keck, & Riechelmann, 2006) and human corneal cells (Ye, et al., 2011) at concentrations 
far below those present in surface disinfecting solutions. 
 Hydrogen peroxide based cleaners have become increasingly popular as a less toxic 
alternative to chlorine-based bleaches for stain removal (Wentz, Lloyd, & Watt, 1975). Studies 
on the biological effects of hydrogen peroxide have shown that it can alter the concentrations of 
different types of ions within cells (Halliwell & Aruoma, 1991) and cause significant DNA 
damage through the generation of free radicals (Imlay & Linn, 1988). Hydrogen peroxide in 




larger quantities has also been shown to inhibit the PCR amplification of DNA extracted from 
blood samples (Akane, 1996). These properties illustrate the potential of hydrogen peroxide to 
have a measurable, negative impact on DNA present in forensic blood samples, as well as the 
ability of a forensic examiner to successfully develop a genetic profile from treated blood 
samples. A study that examines the effects of hydrogen peroxide solutions on current forensic 
DNA analysis methods across a broad range of concentrations would provide DNA analysts with 
examples of the types of genetic profiles that could be obtained from samples that are treated 
with hydrogen peroxide cleaners. 
1.3 Research Problem 
 
 The field of forensic DNA analysis has been continuously progressing since it first began 
in the 1980’s through the development of new technologies and methodologies. This constant 
advancement has led to current practices which are extremely sensitive and efficient when 
compared with those used originally. Unfortunately, criminals have simultaneously become more 
aware of the importance of biological evidence to investigations. Their attempts to conceal and 
destroy this evidence result in forensic samples that contain various chemical compounds that 
have the potential for negative interaction with the DNA itself, as well as the various components 
of the DNA analysis process. Research is needed that examines the effects that these chemical 
cleaning agents have on more recently developed DNA technologies, such as the PrepFiler 
Express™ Forensic DNA Extraction Kit and the Automate Express™ Forensic DNA Extraction 
System. Further study of the effects that these chemicals have on genetic profiles obtained from 
treated samples is also necessary to provide quantifiable data over a range of concentrations to 
determine the point at which a significant decline in profile quality is observed. 




1.4 Purpose of Research 
 
 The aim of this research was to determine whether three common classes of commercial 
cleaning products have negative effects on current forensic DNA analysis processes when they 
are present in varying amounts in liquid blood samples. More specifically, this research focused 
on whether the Automate Express™ Forensic DNA Extraction System using the PrepFiler 
Express™ Forensic DNA Extraction Kit is able to effectively extract a comparable amount of 
purified DNA free from PCR inhibitors from samples that have been treated with these 
chemicals when compared with untreated control samples. This research also analyzed the 
impact that these three types of cleaning products have on overall genetic profile quality. This 
was accomplished by analyzing the profiles generated from a broad range of cleaner to blood 
ratios within each of the three treatments. This portion of the research was performed in order to 
determine the minimum ratio at which each cleaner begins to have a significant negative effect 
on the genetic profile. The results of this study will allow forensic DNA examiners employing 
current methods to have a better understanding of the capabilities and limitations of their 
technology when processing these types of compromised samples. That knowledge will allow 
analysts to provide more realistic expectations to criminal investigators of the quality of 
information that may be obtained from this evidence. This information can also be used by crime 
scene personnel to assist them when deciding which evidence to collect from a scene that will 
prove to be the most probative. 
 
  




2. LITERATURE REVIEW 
 
2.1 History of Forensic DNA Analysis 
 
 The potential applications for the analysis of DNA in the field of forensic science were 
recognized over thirty years ago. Since that time, the process of isolating and analyzing DNA for 
the purpose of human identification has been a topic of continuous research. Beginning with the 
observation and interpretation of the molecular structure of DNA in the 1950’s and continuing 
through the current methods of microsatellite typing and automation of forensic genetic 
profiling, the field of forensic DNA analysis has experienced dramatic advancements during the 
course of the past three decades.[ (Watson & Crick, 1953); (Butler J. , 2010)] 
2.1.1 The Structure and Molecular Properties of DNA 
 
 The chemical structure of the deoxyribonucleic acid molecule was first elucidated in 
1953 by James D. Watson and Francis Crick through X-ray diffraction as seen in Figure 1 
(Watson & Crick, 1953). The individual unit of DNA is referred to 
as a “nucleotide,” and consists of one of four nitrogenous bases 
attached to a deoxyribose sugar molecule and a phosphate group. 
As individual nucleotides are joined together, these sugar and 
phosphate groups alternate to form the “backbone” of each strand of 
DNA, illustrated in Figure 2. The four bases on the interior of the 
DNA molecule (adenine, thymine, guanine, and cytosine) bond to 
one another through either two hydrogen bonds, in the case of 
adenine and thymine, or three hydrogen bonds, in the case of guanine and cytosine (Chargaff, 
1951).This base pair specific bonding can be seen in Figure 3. These bonds between base pairs 
Figure 1. Photo of the 
crystalline structure of DNA. 
X-ray fiber diagram of DNA 
molecule that shows the double 
helical form. Taken by R.E. 
Franklin and R. Gosling in 
1953. (Watson & Crick, 
1953) 




allow two chains of DNA to hybridize to one another to form the double-stranded, double-helix 
molecular conformation described by Watson and Crick that is the natural state of DNA within 
the cell (Watson & Crick, 1953). 
Figure 3. Complementary base pairing between two DNA 
strands. This diagram depicts the specific structures and 
bonding patterns of each of the bases found in DNA. Thymine 
binds to adenine through two hydrogen bonds, while cytosine 
binds guanine more strongly with three hydrogen bonds. 
(Alberts, Johnson, Lewis, Raff, Roberts, & Walter, 2002) 
 
The directionality of DNA comes from the orientation of the carbon atoms within the 
deoxyribose molecules found in the sugar-phosphate backbone. Within a single nucleotide, the 
phosphate group is attached to the 5’ carbon atom of the sugar molecule, while the base is bound 
at the 1’ carbon. The next nucleotide in the DNA sequence attaches to the hydroxyl group at the 
3’ position, so DNA sequences are traditionally written in the 5’ to 3’ direction. This is also the 
direction that DNA polymerases synthesize new strands of DNA during the replication process. 
(Littauer & Kornberg, 1957) 
 All of the DNA contained within each cell of an individual is referred to as a person’s 
genome. This genetic information is organized in humans into 22 pairs of autosomal 
Figure 2. DNA and its individual components. DNA is 
comprised of nucleotides which each contain a phosphate, a 
sugar, and one of four different bases. The sugar-phosphate 
backbone is formed as multiple nucleotides join together to 
form one DNA strand. Two complementary strands of DNA 
then bond through base pairing to form a double helix. 
(Alberts, Johnson, Lewis, Raff, Roberts, & Walter, 2002) 




chromosomes and 2 sex-determining chromosomes, 
seen in Figure 4, which are replicated identically and 
passed on each time a cell divides through the process 
of mitosis. As a result of this process, the genetic 
information contained within all somatic, or body, cells 
in humans is identical regardless of the tissue or body 
fluid of origin. This is a very important quality of DNA 
for the field of human identity testing. In humans and 
other organisms that reproduced sexually, one 
chromosome from each of the 23 pairs is passed on to the offspring from the male, and the other 
23 chromosomes are inherited from the female, leading to genetic variation between individuals. 
In order for this to be accomplished, gamete cells, either sperm or egg cells, in humans contain 
only half of an individual’s genome organized into a single set of 23 chromosomes (Weismann, 
1893) (Tjio & Levan, 1956). Within a person’s genome, the DNA is organized into 30,000-
40,000 genes, and within these genes are two distinct types of regions. The first type are coding 
regions called exons, which contain the genetic sequences that are actually translated to 
synthesize all of the proteins found in the human body. The second type of DNA makes up the 
noncoding regions, called introns that are not involved in the translation process. These regions 
contain large amounts of repeating DNA sequences, and their function within the genome is still 
a topic of research and debate (Berget, Moore, & Sharp, 1977; Chow, Gelinas, Broker, & 
Roberts, 1977). It is these repetitive, noncoding DNA sequences that have been, and continue to 
be, the focus of forensic biologists for the purposes of human identification. 
 
Figure 4. The chromosomes comprising the 
human genome. Each nucleated cell in the 
human body has 23 pairs of chromosomes, 22 
autosomal pairs and one pair of sex 
chromosomes. The exception is sex cells which 
contain only one copy of each chromosome. 
(Butler J. , 2010) 




2.1.2 RFLP using VNTRs 
 
 The beginning of forensic DNA analysis came with the introduction of restriction 
fragment length polymorphism (RFLP) analysis to detect differences in variable number tandem 
repeats (VNTRs). In certain hypervariable regions within the genome, these short sequences of 
DNA, also called “minisatellites,” are repeated in tandem and the number of repeats present at 
one location on a chromosome is referred to as an “allele.” Since each somatic cell contains 
matched pairs of chromosomes, each person will have two alleles present at each locus. Allelic 
variation between individuals occurs in these hypervariable regions as different individuals have 
different numbers of repeats at each locus. (Jeffreys, Wilson, & Thein, March 1985) 
 In order to determine the number of repeats present at a given locus, Jeffreys used 
restriction enzymes, or endonucleases, that cut DNA strands at a specific location on either side 
of the VNTR in question. This resulted in a DNA fragment of a specific length, based upon how 
many repeats were present (Jeffreys et al., 1985). The size of the specific fragment was 
determined through gel electrophoresis, in which an electrical charge is applied to agarose gel, 
causing DNA to migrate from one end of the gel 
towards the other due to the overall negative 
charge of the molecule. Smaller DNA fragments 
are able to move through the gel more quickly 
than larger fragments, so the size of a specific 
fragment can be determined based upon its 
position on the gel relative to a sizing ladder 
comprised of fragments of known lengths, 
Figure 5. Restriction Fragment Length Polymorphism 
Analysis. DNA from an individual with two different sized 
alleles is digested with restriction enzymes that cut the 
DNA into fragments of different sizes. These are then 
separated based on size on a gel before being transferred to 
a membrane and washed with radioactive probes to allow 
visualization. (Butler J. , 2010) 




illustrated in Figure 5 (Aaij & Borst, 1972). Using various radioactive probes that hybridize to 
different DNA fragments, multiple VNTRs could be visualized on a single autoradiogram using 
X-rays. The combination of alleles from multiple VNTR loci was termed an individual’s “DNA 
fingerprint” by Jeffreys. (Jeffreys, Wilson, & Thein, July 1985) 
The forensic application of the RFLP process was recognized almost immediately after it 
was developed, and it was first applied to forensic type samples by its developers within the 
same year (Gill, Jeffreys, & Werrett, 1985). The process of RFLP typing was further validated in 
1991 in a study that exposed biological samples to a variety of environmental, chemical and 
biological insults, including chlorine bleach, to examine what effect these treatments had on the 
quality and reliability of the resulting RFLP pattern. While the study concluded that RFLP 
analysis was a valid method that produced no false results under any of these conditions, 
multiple samples produced no pattern whatsoever after being exposed to these types of 
conditions and contaminants (Adams, et al., 1991). Despite the fact that RFLP analysis was 
highly discriminating, it has become largely obsolete with regards to forensic DNA analysis due 
to its lengthy analysis process and the fact that it requires greater than 50 ng of intact, high 
molecular weight DNA to develop a reliable profile. Since DNA recovered from evidentiary 
samples has often been degraded by a variety of environmental insults prior to analysis, this 
makes RFLP less effective in a forensic capacity. (Butler J. , 2010) 
2.1.3 The Polymerase Chain Reaction 
 
 A crucial advancement in the history of forensic DNA analysis was the development of 
the polymerase chain reaction, or PCR. This process, developed by Kary Mullis at the Cetus 
Corporation, was first described in an article by Saiki et al. in late 1985 (Saiki, et al., 1985) and 




was later patented by Mullis in 1987 
(Mullis K. B., 1987). PCR allows for 
the copying of a single sequence of 
DNA through multiple cycles in order 
to generate millions of identical 
copies. This is accomplished through a 
series of amplification cycles that 
involve the manipulation of the 
reaction temperature. First, the 
temperature is raised to denature 
double stranded DNA, then lowered to allow fluorescently labeled primers to anneal to the DNA 
region of interest. DNA polymerase then extends the new, complementary strand of DNA 
through the addition of deoxynucleotide triphosphates (dNTPs), and the process begins anew 
with the denaturing of the template and newly synthesized strands from one another so that they 
can each be used as template strands in the next amplification cycle. The process is represented 
in Figure 6, and these steps are repeated continuously until millions of copies of the original 
DNA sequence exist in the sample (Mullis, Faloona, Scharf, Saiki, Horn, & Erlich, 1986). The 
process was later improved through the use of a thermally stable DNA polymerase known as Taq 
polymerase, allowing the entire process to be carried out in one sealed tube since the polymerase 
was no longer inactivated by the extremely high denaturing temperatures (Moretti, Koons, & 
Budowle, 1998). Taq polymerase is isolated from the thermophilic Thermus aquaticus bacterium 
that was first discovered inhabiting thermal springs in Yellowstone National Park and elsewhere 
in California (Brock & Freeze, 1969). 
Figure 6. A model of one cycle of the polymerase chain reaction.  Each 
cycle first requires the denaturation of double-stranded template DNA, 
followed by annealing of forward and reverse primers, then the extension 
of the new DNA segment by the DNA polymerase. Then the product and 
template strands are denatured from one another and the process begins 
again. (Bloch, 1991) 




 The PCR process was critical to the advancement of forensic DNA typing, as analysts 
could now generate millions of copies of the DNA present in extremely low quantity or degraded 
biological evidence samples. This represented a significant improvement over RFLP methods 
that required intact DNA samples that were several thousand bases long. PCR amplification 
capabilities necessitated the development of a profiling system that utilized much smaller, but 
still highly variable DNA sequences, which led to the advancements discussed in the following 
section. (Li, 2008) 
2.1.4 Short Tandem Repeat Profiling 
 
 Short tandem repeats (STRs), or microsatellites, are small segments of noncoding DNA 
that contain a 2-7 base pair sequence that is repeated a variable number of times. These repetitive 
DNA markers were first studied in the late 1980’s and the advantages of applying STRs to 
forensic DNA typing were established as early as 1988 (Craig, Fowler, Burgoyne, Scott, & 
Harding, 1988). Although a single STR locus does 
not provide the same level of discrimination as a 
typical VNTR locus, the relatively small size of 
each STR allows several separate loci to be 
amplified simultaneously through multiplex PCR 
which exponentially increases the discriminating 
power (Edwards & Gibbs, 1994). In an effort to 
standardize the STR loci being typed in forensic 
labs, the Federal Bureau of Investigation 
designated 13 specific loci, pictured in Figure 7, as the “core” loci to be used to generate a 
complete genetic profile for comparison and for entry into the U.S. national DNA database, the 
Figure 7. The 13 CODIS core STR loci with 
chromosomal positions. These 13 loci were chosen by the 
FBI as the standardized set used to generate a genetic 
profile that can be entered into the U.S. federal DNA 
database, the Combined DNA Indexing System. (Butler & 
Reeder, Short Tandem Repeat DNA Internet DataBase, 




Combined DNA Indexing System (CODIS).  Multiplex systems were validated in the late 1990’s 
that incorporated these 13 loci, allowing forensic analysts to now generate standardized genetic 
profiles from samples containing only a fraction of the amount of DNA required for previous 
DNA typing methods. Furthermore, the development of fluorescent tags and capillary 
electrophoresis made STR typing significantly safer and more efficient than RFLP analysis 
(Moretti, Baumstark, Defenbaugh, Keys, Smerick, & Budowle, 2001). All of these advantages 
have led to worldwide acceptance of STR typing as the optimum method for forensic DNA 
analysis for more than 20 years. 
2.2 Current Forensic DNA Analysis Methods 
 
 The history of forensic DNA analysis over the past three decades that was described in 
the previous sections has culminated in the current processes employed by public and private 
labs worldwide. The general steps involved in the forensic DNA analysis process include 
extraction of DNA from biological samples, quantification of the amount of DNA present in a 
sample, amplification of the DNA, and finally, separation and detection of the individual 
amplified DNA fragments to generate a genetic profile. There are various specific methods and 
technologies available for each of these four steps, however, the processes described in the 
following sections are only those currently employed by the Forensic Biology Unit at the 
Oklahoma State Bureau of Investigation’s Forensic Science Center, where this research study 
was conducted. 
2.2.1 Extraction of DNA with the Prepfiler Express™ Forensic DNA Extraction Kit 
 
 The initial step in any type of forensic DNA analysis is extraction of the DNA itself from 
all other biological material and contaminants present in an evidentiary sample. In the current 




study this is accomplished through the use of the Prepfiler Express™ Forensic DNA Extraction 
Kit used in conjunction with the Automate Express™ Forensic DNA Extraction System. The 
original Prepfiler™ extraction kit was developed by Applied Biosystems® in 2008 and binds the 
DNA from lysed cells to the surface of magnetic particles in order to keep it stable during 
multiple wash steps that remove the rest of the cellular material that can interfere with 
downstream PCR processes. The purified DNA is then removed from the particles using an 
elution buffer with a different chemical composition (Brevnov, Pawar, Mundt, Furtado, & 
Shewale, 2008). The manual system was validated using a variety of samples including liquid 
blood samples and samples with various known PCR inhibitors. The authors used the results 
from quantification data to conclude that the PrepFiler™ kit efficiently removed all PCR 
inhibitors that had been introduced to the samples. The study also compared the PrepFiler™ kit 
to several other extraction methods, and showed that it produced higher concentrations of 
extracted DNA from a variety of different types of samples. (Brevnov, Pawar, Mundt, Calandro, 
Furtado, & Shewale, 2009) 
 An additional benefit to the PrepFiler™ chemistry is that it was able to be modified for 
an automated DNA extraction system. For this purpose, Applied Biosystems developed the 
PrepFiler Express™ Forensic DNA Extraction kit for use in the Automate Express™ DNA 
Extraction System. A preliminary validation of this system concluded that it was able to improve 
the quality of DNA obtained by removing potential inhibitors, while also significantly reducing 
the amount of time required for DNA extraction (Balsa, et al., 2011) These results were similar 
to those obtained in a more extensive study of the system conducted in 2012 which determined 
the Automate Express™ System was able to extract DNA of sufficient quantity and quality, with 
PCR inhibitors effectively removed, for all case-type samples that were tested (Liu, et al., 2012). 




In an additional study, this automated system was also compared to two other extraction methods 
and the Automate Express™ System using the PrepFiler Express™ kit recovered higher 
quantities of DNA as well as more efficiently removing PCR inhibitors. (Bogas, Balsa, Carvalho, 
Anjos, Pinheiro, & Corte-Real, 2011) 
 Since this extraction system is relies upon an optimized, multi-component surface 
chemistry in order to successfully bind, wash and elute purified DNA (Brevnov, Pawar, Mundt, 
Calandro, Furtado, & Shewale, 2009), it is reasonable to suspect that a sample containing 
additional chemical solutions, i.e. bleach, disinfectants, etc., might affect the system’s ability to 
effectively extract high quantities of DNA while simultaneously removing PCR inhibitors. The 
current research investigated this question using samples containing various concentrations of 
contaminating chemical solutions. 
2.2.2 Quantification of DNA through Real-Time PCR Using the Quantifiler® Human DNA 
Quantification Kit 
 
 Once the purified DNA has been extracted from a sample, the amount of DNA present 
must be determined in order to generate the optimal initial DNA concentration in the 
downstream PCR reaction. One of the most effective methods available to accomplish this is 
Real-Time PCR, which was first introduced in 1992 by scientists at Roche Molecular Systems 
Inc. Originally, the method was developed as a way of monitoring the successful amplification of 
DNA through PCR while the reaction was occurring, eliminating the need for labor intensive 
confirmatory tests for PCR products after the amplification process was completed. This 
monitoring method was accomplished by the addition of ethidium bromide to the reaction, a 
compound whose fluorescence increases in the presence of double-stranded DNA. Recording the 




amount of fluorescence present throughout the reaction indicated whether the amount of DNA 
present was increasing after each PCR cycle. (Higuchi, Dollinger, Walsh, & Griffith, 1992) 
 This method has since been improved and optimized for the purposes of forensic human 
identification resulting in the current process which utilizes the Quantifiler® Human DNA 
Quantification Kit (Applied Biosytems®) and analyzes samples on a 7500 Real-Time PCR 
System (Applied Biosystems®). This kit capitalizes upon the 5’ exonuclease activity of the Taq 
polymerase described in Section 2.1.3 of this chapter. This polymerase activity cleaves double-
stranded DNA in the 5’  3’ direction releasing individual nucleotides and small DNA 
fragments (Holland, Abramson, Watson, & 
Gelfand, 1991). To take advantage of this 
activity, the Quantifiler® kit contains a probe, 
called the Taqman® probe, which hybridizes to 
a small section of the target sequence which is a 
portion of the human telomerase reverse 
transcriptase gene that was selected due to its 
singularity and similarity in size to the STR loci 
amplified downstream in forensic analysis. This 
probe contains a fluorescent “reporter” dye on 
the 5’ end and a second “quencher” dye on the 
3’ end. As long as the probe is intact, the 
quencher dye suppresses the fluorescence of the 
reporter dye using Förster-type energy transfer, however, when the Taq polymerase encounters 
the probe during synthesis of the new PCR product, the exonuclease activity releases the reporter 
Figure 8. Detection of PCR amplification through 
fluorescent probes. In the initial phases of the reaction, two 
dyes, a reporter dye and a quencher dye, are both attached to 
the probe and the emission of the reporter is quenched. As 
the DNA polymerase extends the new DNA product, it uses 
its 5’ nuclease activity to cleave the reporter dye from the 
probe, allowing it to fluoresce and be detected. (Applied 
Biosystems, 2001) 




dye on the 5’ end first, and the resulting fluorescent signal can be recorded (pictured in Figure 8).  
The intensity of the fluorescent signal increases with each PCR cycle as more and more 
Taqman® probes are released from the increasing number of DNA template strands. Eventually, 
the signal will reach a specific threshold where it can be reliably distinguished from all 
background fluorescence. The cycle at which the fluorescence crosses this line is called the 
“Threshold Cycle”, or CT, and the CT for a sample is inversely proportional to the amount of 
DNA template present at the beginning of the PCR process. In other words, the more DNA is 
present in a sample prior to PCR, the lower the CT for the given sample will be. The CT value for 
a sample can be compared to a standard curve generated from samples with known DNA 
concentrations in order to determine the exact concentration of DNA present, reported in ng of 
DNA/µL of extract. (Green, Roinestad, Boland, & Hennessy, 2005) 
 An additional feature of the Quantifiler® kit is the inclusion of an Internal PCR Control 
(IPC) that allows for the detection of substances inhibiting amplification during the 
quantification process. The IPC system consists of a synthetic DNA sequence, primers to 
specifically amplify this synthetic sequence, and a probe similar to the one described previously 
that is labeled with a different reporter dye. If a sample truly contains little to no DNA, then this 
synthetic DNA sequence will display normal amplification with a CT value between 20 and 30 
cycles. If the sample displays an artificially low quantification value due to PCR inhibition 
however, the amplification of the IPC sequence will also be inhibited leading to a higher CT 
value (Applied Biosystems, 2006). In forensic casework, these results would be used to 
determine if a sample needed to be re-purified or re-extracted before moving on to STR 
amplification, but in a research context the IPC can be used to determine the effectiveness of an 




extraction method at removing inhibitors that have been added to a sample as seen in the 
validation of the Prepfiler Express® system. (Balsa, et al., 2011) 
2.2.3 Multiplex PCR Amplification using the AmpFLSTR® Identifiler® Plus PCR 
Amplification Kit 
 
 Once the amount of DNA present in a given sample has been determined, it can be 
effectively amplified using PCR. Currently, many forensic biology laboratories employ the 
AmpFLSTR® Identifiler® Plus PCR Amplification Kit to accomplish this. The Identifiler® Plus 
kit is a multiplex STR assay, which means multiple loci are all amplified simultaneously. The 
loci amplified are 15 tetranucleotide repeat loci, including the 13 core CODIS loci, and the 
Amelogenin marker used for gender-determination (Applied Biosystems, 2009). The kit contains 
fluorescently labeled forward and reverse primers, an allelic ladder containing amplified alleles 
commonly reported at each locus, control DNA 9947A with a known profile, and an 
amplification master mix made up of Taq DNA polymerase, deoxynucleotide triphosphates 
(dNTPs), salts, and sodium azide. (Applied Biosystems, 2009) 
 Once the primers and reaction mix have been combined with the correct amount of a 
sample extract to target approximately 1 ng of DNA, the mixture is placed onto a thermal cycler 
where it undergoes an initial incubation at 95°C in order to activate the AmpliTaq Gold® DNA 
Polymerase, followed by 28 PCR cycles. Each cycle features a 94°C step to denature the double-
stranded DNA, before moving to 59° to allow annealing of the primers to the DNA template and 
elongation of the newly synthesized DNA by the polymerase. Following the 28 amplification 
cycles, the reaction is held at 60°C for 10 minutes to allow for complete extension of each DNA 
fragment. These standard thermal cycling parameters were determined during the course of the 
validation of this PCR kit by Wang et al. This validation also established that this kit displayed 




greater sensitivity and a better ability to overcome PCR inhibitors when compared to previous 
amplification kits. (Wang, Chang, Lagace, Calandro, & Hennessy, 2012) 
2.2.4 Detection of PCR Products Using Capillary Electrophoresis 
 
 After the original DNA template in a sample has been amplified using the Identifiler® 
Plus kit to produce millions of copies, the individual STR loci must be separated from one 
another in order to generate an individual’s genetic profile. In the field of forensic science, this is 
currently accomplished through the use of capillary electrophoresis. This separation method was 
first applied to forensic STR 
fragments in the early 1990’s  
and operates in general by 
forcing the fluorescently-
labeled DNA fragments through 
a narrow glass capillary filled 
with a sieving polymer 
(McCord, Jung, & Holleran, 
1993). The negatively charged 
DNA migrates from the cathode 
end of the capillary to the anode 
end once an electrical current 
has been applied, and as it 
moves, the smaller fragments are able to pass through the sieving polymer more quickly while 
the larger fragments get caught and are slowed down. This leads to separation of the individual 
Figure 9. Components of a capillary electrophoresis system. Within a capillary 
electrophoresis system, DNA migrates from one end (cathode) of the capillary to 
the other (anode) when an electrical current is applied. As it migrates, the DNA 
fragments are separated based upon their sizes before passing through a detection 
window where a laser excites the fluorescent labels and a charge-coupled camera 
records the emissions. (Butler & McCord, 2004) 




PCR products by the time they reach the detection window in the capillary where the fluorescent 
tags are excited with a laser light source causing them to emit light which is then translated into 
an electrical signal that can be recorded by a computer to be compared to a sizing standard that is 
run simultaneously, giving the exact size of the DNA fragments in question. These fragments are 
then separated first by which color of fluorescent dye was used to label them, and then by their 
size within each dye channel in order to generate an electropherogram. A general depiction of 
this type of system is shown in Figure 9. (Butler & McCord, 2004) 
2.3 DNA Damage and Amplification Inhibition 
 
 In forensic DNA analysis, the successful recovery of a useful STR profile is not always 
possible, even in evidentiary samples that contain a sufficient amount of biological material. 
Two of the major causes for this lack of success are often DNA degradation and inhibition of 
PCR amplification. DNA degradation can occur due to various agents that are endogenous, 
occurring naturally within an organism, or exogenous, originating from outside sources (De Bont 
& van Larebeke, 2004). This damage to the DNA molecule comes in various forms including 
single- or double-strand cleavage, chemical modification of the individual bases, and 
depurination, in which adenine and guanine bases are released from the molecule (Lindahl, 
1993). In a living organism, these types of damage can often be repaired by specific enzymes to 
prevent incorrect or incomplete replication (Sancar, Lindsey-Boltz, Unsal-Kacmaz, & Linn, 
2004), however in non-replicating cells that have been removed from the body, like the ones 
comprising forensic biological samples, these enzymes are typically no longer active and the 
damage is permanent.  




 The second major challenge in attempting to generate a complete and useful forensic 
DNA profile is the inhibition of the PCR amplification process by substances that are present 
within forensic samples following DNA extraction. Some common examples of these types of 
substances include humic acid in soil, heme in blood, heavy metals, urea, collagen, certain types 
of carbohydrates, and even excessive amounts of DNA itself. Inhibitors can affect all 
components of the PCR process including interfering with primer binding, altering Mg2+ 
concentration, inhibiting the action of the DNA polymerase, or modifying the free nucleotides or 
DNA template, all of which can lead to heterozygous peak height imbalance, allelic dropout, or 
complete failure of the amplification reaction (Alaeddini, 2012). Three commonly encountered 
chemical compounds that can cause both of these particular issues in forensic samples are 
reviewed in the following sections. Each of the chemicals discussed are the major active 
ingredient in various types of commercially available cleaning products that might be used to 
conceal or destroy biological evidence. 
2.3.1 Sodium Hypochlorite 
 
 One of the most common agents used for cleaning and disinfection purposes is chlorine 
bleach. The most common type of chlorine bleach available today has an active ingredient of 
sodium hypochlorite. Chlorine was first discovered in 1774 by Swedish chemist C.W. Scheele, 
and the first liquid bleaching agent was produced in 1785 in France, but liquid bleach did not 
become commercially marketed in the United States until the early 1900’s (Baldwin, 1927). In 
the 1970’s, Hayatsu et al. studied the effects that sodium hypochlorite had specifically on nucleic 
acids. They studied the changes produced in the UV spectra of isolated nucleosides after 
treatment with both 10 ppm and 100 ppm sodium hypochlorite and determined that the chemical 
structure of each individual base was altered to generate products that extensively reduced UV 




absorption. The study went on to attempt to identify which specific products were made, but for 
the purposes of DNA amplification and analysis any alteration to the bases present in the DNA 
molecule would render it useless for human identification, regardless of what the specific 
products were. (Hayatsu, Pan, & Ukita, 1971) 
 In 1973, a study was conducted to examine the effects of sodium hypochlorite on DNA in 
its natural state within the cell. The authors exposed bacterial cells that were deficient in DNA 
polymerase I, the enzyme responsible for repairing damaged DNA, to sodium hypochlorite and 
found that the growth of this bacterial strain was inhibited to a greater extent than normal 
bacteria exposed to the same treatment. This data showed that the inhibition was due to damage 
inflicted directly to the DNA of the organism by sodium hypochlorite, rather than just damage to 
other cellular structures (Rosenkranz, 1973). This attribute of sodium hypochlorite led to the use 
of dilute chlorine bleach as the preferred method for the decontamination of forensic lab spaces 
and equipment as it was able to alter or destroy exogenous DNA to the point that it was no 
longer able to amplified using PCR. Vandewoestyne et al. found that the number of alleles 
detected was significantly lower in samples collected from various lab areas and equipment after 
such decontamination procedures as opposed to before (Vandewoestyne, et al., 2011). An 
additional forensic application of the DNA-damaging properties of sodium hypochlorite was 
explored in two similar studies in which the solution was used to remove contaminating DNA 
from the surface of both forensic (Rennick, Fenton, & Foran, 2005) and ancient (Kemp & Smith, 
2005) skeletal remains and teeth. The first study examined the effects of sodium hypochlorite 
decontamination on the endogenous DNA that an analyst would want to successfully extract and 
determined that the bleach treatments degraded this DNA significantly. The second study was 
more focused on the successful removal of contaminating DNA from the surface of ancient 




remains, however, the authors did come to a somewhat contradictory conclusion that sodium 
hypochlorite did not damage the endogenous DNA of the bones, but did destroy the exogenous 
DNA. 
 All of the research discussed thus far regarding the effect of sodium hypochlorite on 
DNA has used isolated nucleotides, epithelial cells, or DNA found in bones and teeth; a final 
study of relevance to this project examines various types of DNA damage, including that 
inflicted by sodium hypochlorite solutions, in liquid blood samples. The authors determined that 
when liquid blood was immersed in a commonly used 10% bleach solution (0.6% sodium 
hypochlorite), full STR profiles were still obtained, even after a 2 hour incubation period. When 
the concentration of sodium hypochlorite was increased to 3%, however, allelic dropout occurred 
after a 1 hour incubation, and complete profile loss was seen after 2 hours. (Ambers, Turnbough, 
Benjamin, King, & Budowle, 2014)  
 A final study that examined the negative effects of chlorine bleach on forensic DNA 
analysis was conducted in 2011. This study examined two types of commercial disinfecting 
solutions and compared them to Clorox® bleach in order to determine if they could be used as an 
alternative method for the sterilization of forensic laboratory workspaces and equipment. During 
the course of this study, different concentrations of each solution were added to DNA that had 
previously been extracted from a blood sample, and the extracts were then quantified and 
amplified. The results from both the Internal PCR Control recorded during quantification as well 
as the final STR profiles support the conclusion that chlorine bleach is highly inhibitive to the 
PCR process when present in a forensic sample following the extraction process. (O'Brien & 
Figarelli, 2011) 




2.3.2 Quaternary Ammonium Compounds 
 
 The second type of cleaning agent of concern to 
this research consists of solutions that contain a class of 
chemicals called quaternary ammonium compounds, or 
QACs. The specific type of QAC found in the 
disinfectant cleaner selected for this research is alkyl 
dimethyl benzyl ammonium chloride (Reckitt Benckiser, 
2013), generally known as  benzalkonium chloride 
(BAC), pictured in Figure 10. QACs are classified as 
“cationic surfactants”, and consist of a hydrophobic, 
hydrocarbon group and a positively-charged, hydrophilic group. The value of QACs as 
antiseptics and disinfectant cleaners comes from their interactions with the cell membranes of 
infectious agents eventually leading to cell lysis and death (McDonnell & Russell, 1999). The 
specific mechanism of this interaction has been described by Salton in the following five steps: 
“(1) Adsorption and penetration of porous wall (2) Interaction with lipid-protein membrane; 
reaction with hydrophobic proteins, oriented lipids; membrane disorganization (3) Leakage of 
low molecular weight metabolites, e.g. amino acids, purines, pyrimidines, nucleotides, ions (4) 
Degradation of proteins, nucleic acids (5) Lysis due to wall-degrading autolytic enzymes” 
(Salton, 1968).  
 Since the major commercial value of QACs lies in their antimicrobial properties, most of 
the research conducted using these compounds has examined the toxic effects on bacterial cell 
viability following exposure to QACs. A study of this type by Deutschle et al., however, also 
included an investigation of the genotoxic effects of QACs, specifically benzalkonium chloride. 
Figure 10. The chemical structure of 
benzalkonium chloride (BAC). BAC is a type 
of quaternary ammonium compound in which 
the nitrogen is bound to a benzyl group, two 
methyl groups and an even-numbered alkyl 
chain. (ChEBI: The Database and Ontology 
of Chemical Entities of Biological Interest, 
2014) 




The authors describe genotoxicity as the ability of an agent, chemical or otherwise, to cause 
damage specifically to DNA, including strand breaks. They found that exposure to increasing 
levels of BAC led to DNA single-strand breaks as well as other DNA lesions that are precursors 
to strand breaks (Deutschle, Porkert, Reiter, Keck, & Riechelmann, 2006). An additional study 
published in 2007 studied the effects of QACs on both mammalian and plant cells. This study 
documented increased amounts of DNA damage following exposure to two different types of 
QACs (Ferk, et al., 2007). 
 One final study of BAC examined the effects of the compound on DNA found in human 
cells, specifically human corneal epithelial cells. The cells were exposed to doses of BAC 
ranging from only 0.00005% to 0.001% before being tested for the presence of both single- and 
double-strand DNA breaks. The authors found that as the concentration of BAC was increased, 
the amount of both types of DNA damage increased as well. The study went on to determine that 
even after 24 hours of cell recovery from these treatments, the damage was only partially 
repaired through natural cellular mechanisms (Ye, et al., 2011). It is notable that the maximum 
concentration of BAC used in the previously described experiment was approximately 100 times 
more diluted than the concentration of BAC present in the disinfectant cleaning product selected 
for this research.  
2.3.3 Hydrogen Peroxide 
 
 Another type of disinfecting agent that has become common more recently consists of 
solutions containing hydrogen peroxide as the active ingredient. Hydrogen peroxide was first 
reported in the early 19th century and was first marketed as a disinfectant approximately 50 years 
later (Block, 2001). Because the compound has very low toxicity to humans, animals, and the 




environment in general, it is useful not only to destroy bacteria and viruses on materials that may 
come in contact with food or drink, but also for the sterilization of the consumables themselves 
such as drinking water (Yoshpe-Purer & Eylan, 1968) or milk (Naguib & Hussein, 1972). 
Hydrogen peroxide occurs naturally within human cells, and its biocidal properties are evident as 
it is one of the compounds that destroy infectious agents in both the mucous membranes and in 
the bloodstream. (Block, 2001) 
 Although hydrogen peroxide is a compound that occurs naturally within cells, exposure 
to increased levels of the chemical can damage cells in various ways including disruption of 
membrane lipids leading to cell lysis, as well as damage directly to the cellular DNA. The latter 
of these types of damage is of particular interest to researchers in both medical and forensic 
science. The negative effects that are exerted upon cells by hydrogen peroxide and other related 
chemical species have been termed “oxidative stress,” and, in the case of DNA, this stress 
typically comes in the form of free radicals that attack both the sugar-phosphate backbone of the 
molecule and the individual nitrogenous bases (Imlay & Linn, 1988). Two mechanisms by which 
DNA damage is caused within the cell from hydrogen peroxide exposure were put forth by 
Halliwell and Aruoma. In the first theory, increased hydrogen peroxide exposure causes 
increased release of copper or iron ions within the cell. These ions then bind directly to cellular 
DNA before being oxidized by hydrogen peroxide to generate the hydroxyl radical. This 
powerful free radical then attacks the DNA that is bound to the metal ions and induces strand 
breakage and base modification. The second mechanism of DNA damage proposed by the 
authors describes the inhibition of the cell’s ability to extrude excess calcium ions (Ca2+). This 
leads to an increase in intracellular free Ca2+ ions, which in turn leads to the activation of 
endonucleases present within the cell. These endonucleases then proceed to sever DNA strands 




causing fragmentation without any base modification (Halliwell & Aruoma, 1991). Despite 
several studies describing the damaging effects of hydrogen peroxide on DNA, when these 
principles were applied to forensic samples in a study conducted in 2014, the investigators were 
unable to induce significant damage to the DNA in either whole human blood or bloodstains on 
fabric samples. No significant interference with STR typing results was seen in either set of 
samples with the exception of a slight reduction in allele peak heights. (Ambers, Turnbough, 
Benjamin, King, & Budowle, 2014) 
 A final property of hydrogen peroxide that is of particular interest with regards to 
forensic blood evidence relates to inhibition of the PCR process. In a series of studies conducted 
in Japan in the 1990’s, hydrogen peroxide was examined with respect to its effect on PCR 
amplification of DNA extracted from blood and bloodstains. The studies were able to produce 
evidence that when large quantities of hydrogen peroxide are present in the reaction, it inhibits 
amplification, however, when DNA extracts were treated with smaller volumes of hydrogen 
peroxide and the chemical was then precipitated out of the sample prior to amplification, the 
PCR efficiency was actually increased. This was likely due to the fact that hydrogen peroxide is 
able to decompose the heme compound found in blood that can inhibit PCR (Akane, 1996). The 
current literature illustrates that the possible effects of hydrogen peroxide with regards to DNA 
damage and interference with forensic analysis methods are varied and dependent upon many 
factors, including concentration, other compounds present in a sample, and time of exposure. 
Research is needed that controls and isolates these variables while providing a more accurate 
model of the possible interaction between blood and hydrogen peroxide that might occur in a 
forensic setting.  




3. MATERIALS AND METHODS 
 
3.1 Preparation of Dilution Series, Control Samples, and Experimental Samples 
 
 A series of five dilutions of whole blood was prepared by combining whole human blood 
with phosphate buffered saline (PBS). The blood sample was a single-source, male sample 
obtained from Innovative Research™ (Novi, MI), lot number 23 51253, and contained sodium 
ethylenediamminetetraacetate (NaEDTA) as an anticoagulant. The dilution series consisted of a 
neat blood sample, a 1:2 blood:PBS sample, a 1:10 blood:PBS sample, a 1:100 blood:PBS 
sample, and a 1:1000 blood:PBS sample. The volumes used to prepare these dilutions are listed 
in Table 1. Once prepared, the five blood dilutions were stored at ~2°C. 
Table 2: Volumes of Blood and PBS Used to Prepare Dilution Series 
Dilution 
Volume of Blood 
Used (mL) 




Neat 10.0 0 10.0 
1:2 3.5 7.0 10.5 
1:10 1.0 10.0 11.0 
1:100 0.1 10.0 10.1 
1:1000 0.01 10.0 10.01 
 
A dilution set was prepared in the same manner as above for each one of three 
commercial cleaning products. The first cleaning solution selected was Clorox® Regular-Bleach 
(The Clorox Company, Oakland, CA), which has an active ingredient of 8.25% sodium 
hypochlorite. The second product was Lysol® Multi-Surface All-Purpose Cleaner (Reckitt 
Benckiser LLC, Slough, Berkshire, UK), containing an active ingredient of 0.1076% dimethyl 




benzyl ammonium chlorides, which belong to the group of chemical compounds referred to as 
quaternary ammonium compounds, or QAC’s. The final cleaning product chosen was Resolve® 
Carpet Cleaner (Reckitt Benckiser LLC, Slough, Berkshire, UK), which has an active ingredient 
of <2.5% hydrogen peroxide. The cleaners were diluted with ultrapure, deionized water, rather 
than PBS. Once prepared, these three dilution sets were stored at room temperature. 
A set of untreated blood samples from each of the five dilutions was prepared to be used 
as control samples. Approximately 200 µL of each blood dilution was combined with 200 µL of 
ultrapure deionized water in a 1.5 mL microcentrifuge tube. Water was added to simulate effects 
that might occur in the treated samples due to dilution of the sample by the additional liquid of 
each cleaning product. A reagent blank for the control sample set was prepared by combining 
200 µL of PBS and 200 µL of deionized water. Each sample was vortexed thoroughly and stored 
at room temperature for 1 hour before beginning the DNA extraction protocol described in the 
subsequent section. 
Three sets of experimental samples were prepared by combining 200 µL of each blood 
dilution with 200 µL of each cleaning product dilution in a 1.5 mL microcentrifuge tube. For 
example, experimental set 2 consisted of samples of blood combined with bleach, therefore 
Sample 2A contained 200 µL of neat blood combined with 200 µL of neat bleach. Sample 2B 
consisted of 200 µL of neat blood combined with 200 µL of 1:2 bleach dilution, etc. A complete 
list of all samples prepared in the course of this study is depicted in Appendix A. A reagent blank 
was prepared for each of the three treated sample sets by combining 200 µL of each of the neat 
cleaning solutions with 200 µL of deionized water. All samples were vortexed and stored at 
room temperature for 1 hour before being processed using the DNA extraction protocol 
described in the subsequent section. 




3.2 DNA Extraction 
 
 Three replicates from each of the samples from Set 1 (control samples), Set 2 (treated 
with bleach), Set 3 (treated with Lysol®), and Set 4 (treated with Resolve®) were extracted using 
the PrepFiler Express™ Forensic DNA Extraction Kit chemistry with the Automate Express™ 
Forensic DNA Extraction System instrument. A reagent blank was also extracted in triplicate for 
each sample set, with the exception of Set 1 which contained only one reagent blank sample. One 
of these three blanks was extracted during each run on the Automate Express™ instruments. 
Samples were extracted according to the protocol found in the PrepFiler Express™ Forensic 
DNA Extraction Kit User Guide (Life Technologies Corporation®, 2010). Prepfiler Lysep™ 
columns were inserted into each of the hinge less Prepfiler™ sample tubes. Next, 40 µL of each 
sample was pipetted into a PrepFiler® Lysep Column/hinge less tube assembly, as depicted in 
Figure 11. Approximately 500 μL of PrepFiler® lysis buffer and 5 μL of 1M Dithiothreitol 
(DTT) were added individually to each sample. The samples were then 
placed onto an Eppendorf Thermomixer® C (Hamburg, Germany) and 
incubated at 70°C while shaking at 750 rpm for 40 minutes. After 
incubating, each column/tube assembly was centrifuged for two 
minutes at ~10400 rpm to transfer the sample lysate to the hinge less 
sample tube. The Lysep™ columns were then removed from the 
sample tubes and discarded. 
 Preparation of the Automate Express™ instrument is depicted 
below in Figure 12. The cartridge rack was loaded first with 13 
Prepfiler Express™ reagent cartridges before being placed on the 
Figure 11. Prepfiler® Lysep 
Column/hinge less tube 
assembly. Sample lysate is 
transferred from the Lysep 
column to the hinge less 
sample tube when the thin 
filter at the base of the 
column breaks upon 
centrifugation. The sample 
tube can then be separated 
and placed directly into the 
instrument. 




instrument. Each of the hinge less sample tubes containing the sample lysates was placed into 
row S of the tip and tube rack. Row T2 was loaded with Automate Express™ Tips inserted into 
tip holders, and Row E was loaded with labeled Prepfiler™ Elution Tubes before the tip and tube 











The “PF Express” protocol on the Automate Express™ system was selected and, once completed, 
the elution tubes containing approximately 50 µL of purified DNA extract were closed and 
removed from the instrument. These DNA extracts were stored at approximately 2°C, while all 
other plastics were removed from the instrument and discarded. 
 
Figure 12. Preparation of the Automate Express™ system prior to DNA extraction. Figures depicting the Automate 
Express™ system (upper left), the cartridge rack with 13 Prepfiler Express™ reagent cartridges that is loaded first (upper 
right), the tip and tube rack with sample tubes containing lysate in row S and elution tubes that will contain DNA extract 
in row E (lower left), and the instrument with both loaded racks placed inside (lower right). 




3.3 DNA Quantification 
 
 Each one of the purified DNA extracts was quantified using the Quantifiler® Human 
DNA Quantification Kit (Applied Biosystems®) on an Applied Biosystems® 7500 Real-Time 
PCR System according to the “DNA Quantification” protocol found in the Oklahoma State 
Bureau of Investigation’s Forensic Biology Unit Policy Manual, Revision 4 (2014). Prior to 
quantification, 1:20 dilutions of each sample containing neat blood and 1:10 dilutions of each 
sample containing 1:2 blood were prepared. This was done to simplify the targeting of 1 ng of 
DNA downstream during amplification in the likely event that these samples contained high 
amounts of DNA. A serial dilution set of standards with known DNA concentrations was 
prepared by diluting the 200 ng/µL stock DNA solution contained in the Quantifiler® kit with 
TE-4 buffer (Tris-HCl + EDTA). These standards were used to generate a standard curve for 
comparison, and the concentrations of each of the eight standard solutions were as follows: 
Standard A- 50.000 ng/µL, Standard B- 16.700 ng/µl, Standard C- 5.560 ng/µL, Standard D- 
1.850 ng/µL, Standard E- 0.620 ng/µL, Standard F- 0.210 ng/µL, Standard G- 0.068 ng/µL, and 
Standard H- 0.023 ng/µL. A master mix was prepared by combining 10.5 µL of the Quantifiler™ 
Human Primer Mix per sample with 12.5 µL of the Quantifiler™ PCR Reaction Mix per sample. 
This master mix was dispensed into each necessary well of a MicroAmp® Optical 96-Well 
Reaction Plate (Applied Biosystems), followed by 2 µL of each standard, sample, or reagent 
blank. Plates were then sealed using a MicroAmp® Optical Adhesive Film and centrifuged 
briefly at approximately 3700 rpm to remove all air bubbles from the bottom of the wells. 
 The reaction plates were loaded onto an Applied Biosystems® 7500 Real-Time PCR 
System and the appropriate standard and sample names were entered into the plate set-up in the 
7500 Software program. The samples were first subjected to a 10 minute hold at 95°C to activate 




the Taq polymerase before undergoing 40 PCR cycles each consisting of 15 seconds at 95°C 
followed by 1 minute at 60°C. After ensuring that none of the negative control samples showed 
any detectable DNA and that the standard curve was acceptable (R2 value ≥ 0.98), the 
concentration value for each sample was then used to target the appropriate amount of DNA in 
the following amplification protocol. These quantification values are depicted in Appendix C. 
3.4 DNA Amplification 
 
 Following quantification, each of the sample sets were amplified using the AmpFLSTR® 
Identifiler® Plus PCR Amplification Kit on an Applied Biosystems® GeneAmp® PCR System 
9700 according to the “DNA Amplification (Identifiler Plus)” protocol found in the Oklahoma 
State Bureau of Investigation’s Forensic Biology Unit Policy Manual, Revision 4 (2014). A 
master mix was prepared by combining 10 µL of the AmpFLSTR® Identifiler® Plus Kit Master 
Mix per sample and 5 µL of the AmpFLSTR® Identifiler® Plus Kit Primer Set per sample. 
Approximately 15 µL of the prepared master mix was added to each 0.2 µL PCR amplification 
tube. The appropriate volume of each sample needed to target approximately 1 ng of DNA was 
then added, before finally adding the necessary volume of TE-4 buffer to bring each total reaction 
volume to approximately 25 µL. For samples that had a quantification value that was either 
undetectable or too low to allow for the addition of 1 ng of DNA to the reaction, the maximum 
volume of 10 µL of the sample was added. The tubes were placed onto an Applied Biosystems® 
GeneAmp® PCR System 9700 thermal cycler and amplified using the “ID Plus (28 cycle)” 
thermal cycling protocol validated internally by the OSBI’s Forensic Biology Unit. This protocol 
consists of a 10 minute initial activation hold at 95°C to activate the Taq polymerase, followed 
by 28 cycles at 94°C for 20 seconds and 59°C for 3 minutes. The final step of the PCR protocol 
was an extension step at 60°C for 10 minutes before the samples were returned to 4°C where 




they remained until they were removed from the instrument and stored in a -20°C freezer. The 
thermal cycling parameters are depicted in Table 2. 
Table 2: Thermal Cycling Protocol for Identifiler® Plus Amplification 
Initial Incubation 
Step 
















3.5 Genetic Analysis 
 
 The amplified DNA products for each set of experimental samples were analyzed using 
capillary electrophoresis on an Applied Biosystems™ 3500 Series Genetic Analyzer. A master 
mix was prepared by combining 8.5 µL of Hi-Di™ Formamide per sample with 0.5 µL of 
GeneScan™ 600 LIZ® dye Size Standard v2.0 per sample. Approximately 9 µL of this master 
mix was dispensed into each necessary well of a MicroAmp® Optical 96-Well Reaction Plate, 
followed by 1 µL of each of the amplified DNA products, including reagent blanks and 
amplification controls. In addition to these samples, 1 µL of the AmpFLSTR® Identifiler® Plus 
Allelic Ladder was also added to one well on the plate. After the plate was covered with a 96-
well septa, it was centrifuged briefly at approximately 3700 rpm to remove any air bubbles from 
the bottom of the wells. The plate was heat denatured by being placed onto a heat block at 95°C 
for 3 minutes, before being snap cooled at 0°C for an additional 3 minutes. The plate was then 
loaded onto the genetic analyzer, the sample names and types were entered into the 3500 
detection software, and the appropriate run parameters were selected (15 second injection at a 
voltage of  15 kV).  




3.6 Data Analysis 
 
The resulting electropherograms were analyzed using GeneMapper® ID-X Software v1.4 
from Life Technologies™. The negative amplification controls and reagent blanks were examined 
to ensure that no peaks were present above the analytical threshold designated for each dye 
channel. These thresholds were selected during the course of the OSBI’s internal validation of 
the 3500 instrument and were as follows: blue dye (PET®)- 100 RFU (relative fluorescence 
units), green dye (NED™)- 190 RFU, yellow dye (VIC®)- 200 RFU, and red dye (FAM®)- 250 
RFU. All other samples were analyzed to determine if there was allelic dropout or imbalance 
between the heights of the two peaks present at each of the heterozygous loci. The peak height 
(measured in relative fluorescence units) of the smaller of the two peaks present at each 
heterozygous locus had to be at least 50% of the peak height for the larger of the two peaks in 
order to be considered “balanced,” according to the casework procedures of the OSBI Forensic 
Biology Unit. Each sample was given a score from 0 to 28 for the number of alleles present on 
the electropherogram, and a score from 0 to 12 for the number of heterozygous loci that were 
balanced (above 50%). Any artifacts visible on the electropherograms were also noted along with 
the likely cause of each artifact. 
  






4.1 Control Data 
 
 The results of Set 1, the untreated blood samples of each dilution, were used as control 
data to be compared to each one of the three experimental sets of treated samples. The first 
category of data recorded for the control samples was the quantification results, which show the 
concentration of DNA present in each sample following the extraction process. The second type 
of data recorded for the control samples consisted of Cycle Threshold (Ct) values for the Internal 
PCR Control (IPC) included in the Quantifiler® Human DNA Quantification Kit. The Ct value 
for a sample indicates the number of PCR cycles required for the amount of DNA in that sample 
to exceed a specific threshold. The more DNA that is present within the sample prior to the PCR 
process, the lower the Ct value, as fewer PCR cycles are required to produce enough DNA copies 
to surpass the threshold. In the case of the IPC for the Quantifiler® kit, the Ct value is used as an 
indicator of whether or not there is a substance present in the sample that is inhibiting the PCR 
process, leading to less efficient amplification of the DNA that is present. This inhibition will 
lead to a high Ct value for the IPC as well as for the sample itself, whereas in a sample that 
simply had low amounts of DNA present without inhibition, the Ct for the sample would be high 
while the IPC Ct value would be similar to what was seen in the quantification standards. Both 
the quantification and the IPC results for each of the individual replicates of Set 1, samples 1A1-
1E3, along with the results for the dilutions of each extract are reported in Appendix B. The 
values from each of the three replicates from each of the blood dilutions were averaged and these 
values, both the DNA concentrations and the IPC Ct’s, for each control sample are recorded in 
Table 3. 










Average IPC Result (Ct) 
1A Neat 5.840 ± 0.676 27.29 ± 0.097 
1B 1:2 1.703 ± 0.135 27.36 ± 0.115 
1C 1:10 0.401 ± 0.024 27.17 ± 0.015 
1D 1:100 0.062 ± 0.008 27.14 ± 0.032 
1E 1:1000 0.003 ± 0.001 27.33 ± 0.116 
 
 The remainder of the data reported for Sample Set 1 consists of scores based upon the 
quality of the genetic profile that was obtained for each sample. These scores were determined 
by analyzing the electropherogram for each sample that was generated by the Genemapper® ID-
X software. The scoring system was based upon the genotype of the donor from which the 
samples were obtained. This genotype is listed below in Table 4.  
Table 4: Genetic Profile of Blood Donor # 59556 


















It should be noted that the profile contains an off ladder allele at the FGA locus, more 
specifically this allele is a microvariant, or an incomplete tetranucleotide repeat for a given 




allele. The calculation for this particular microvariant is displayed below and was confirmed 
through the Variant Allele Reports of the NIST standard reference database SRD 130. (Butler & 
Reeder, Variant Allele Reports, 2006) 
Microvariant Calculation: 
Size of microvariant allele: 236.26 bp 
Size of allele “22” on allelic ladder: 233.22 bp 
236.26 bp – 233.22 bp = 3.04 bp  microvariant allele = 22.3 
 
Microvariants are reported as the number of complete repeat units and are designated as an 
integer, in this case, 22, and any partial repeat is designated as a decimal, followed by the 
number of bases in the partial repeat, giving this allele the designation of 22.3. 
 Using the full profile listed in Table 4, two different scores were given to each sample. 
Since there are 28 total alleles present in the known profile, a score of 0 to 28 was given to each 
sample based upon the number of alleles present above the analytical threshold that were called 
by the Genemapper® ID-X software. This score was used to illustrate the level of allelic dropout 
present in each sample. The second score given to each sample was used to display the 
consistency of peak heights throughout the profile. This was done using the methods listed in 
Section 3.6 “Data Analysis,” and resulted in a score from 0 to 12 for each sample. While the 
individual scores for each sample in Set 1 are displayed in Appendix C, the average numbers of 
allele peaks present for each blood dilution, as well as the average number of heterozygous loci 
with over 50% peak height balance are depicted in Table 5. 
 
 








Average Number of 
Alleles Present 
Average Number of 
Heterozygous Loci Over 50% 
1A Neat 28 ± 0 12 ± 0 
1B 1:2 28 ± 0 12 ± 0 
1C 1:10 28 ± 0 12 ± 0 
1D 1:100 28 ± 0 12 ± 0 
1E 1:1000 25.33 ± 1.53 8.67 ± 0.58 
 
The reagent blank for Sample Set 1, containing only Phosphate Buffered Saline and 
ultrapure, deionized water, was analyzed using all of the same procedures and reported no 
detectable quantification results and had no alleles present on the electropherogram. The positive 
amplification control displayed all of the expected peaks, indicating efficient and accurate 
amplification, while the negative amplification control displayed no peaks above the analytical 
threshold, indicating no contamination of the amplification reagents by extraneous DNA. 
4.2 Samples Treated with Clorox® Regular-Bleach 
 
 For Sample Set 2, liquid blood treated with Clorox® Regular-Bleach, 78 total samples 
were analyzed. The combination of each dilution of blood with each dilution of bleach resulted 
in 25 different mixtures, and three replicates from each one of these mixtures were extracted and 
analyzed. A reagent blank was also prepared containing only neat bleach and ultrapure, 
deionized water, and three replicates of this negative control were also analyzed in the same 
manner. Based upon the color changes observed, it was apparent in several samples that the 
bleach was destroying the red blood cells in the samples by lysing the cell membranes. Samples 
2A and 2B both turned a very dark brown color with slight foaming visible, while several of the 




samples containing diluted blood turned from a bright, translucent red solution to an almost 
colorless, transparent solution with small amounts of precipitate present. Examples of these 
changes are illustrated in Figure 13. 
The dramatic changes that the 
samples in Set 2 underwent as a result 
of the treatment with bleach are 
evidenced quantitatively as well 
beginning with the quantification 
results showing the amount of DNA 
that was extracted from each sample. 
The individual quantification results 
for each of these 78 samples as well as 
any dilutions that were prepared from 
them can be found in Appendix B. 
The results from the three replicates of each sample were averaged and these values were 
compared to the quantification values for each corresponding control sample from Set 1, 
illustrated below in Table 6. 
Table 6: Average Quantification Values for Sample Set 2 vs. Control Samples 
Sample Description 
Average Quantification 
Result (ng DNA/µL) 
Average Quantification 
Value for Control 
Samples (ng DNA/µL) 
2A Neat Blood + Neat Bleach 0.518 ± 0.041 
5.840 ± 0.676 
(Neat Blood) 
2B Neat Blood + 1:2 Bleach 2.010 ± 0.017 
2C Neat Blood + 1:10 Bleach 4.840 ± 0.234 
2D Neat Blood + 1:100 Bleach 5.123 ± 0.532 
2E Neat Blood + 1:1000 Bleach 5.293 ± 0.177 
Figure 13. Comparison of physical appearance of control vs. bleach-
treated samples. Control sample 1B (upper left)- 1:2 blood dilution vs. 
Sample 2F (upper right)- 1:2 blood mixed with neat bleach; Control 
sample 1C (lower left)- 1:10 blood dilution vs. Samples 2K and 2L 
(lower right)- 1:10 blood  mixed with neat bleach and 1:10 blood mixed 
with 1:2 bleach, respectively. 






Result (ng DNA/µL) 
Average Quantification 
Value for Control 
Samples (ng DNA/µL) 
2F 1:2 Blood + Neat Bleach Undet. 
1.703 ± 0.135 
(1:2 Blood) 
2G 1:2 Blood + 1:2 Bleach 0.242 ± 0.012 
2H 1:2 Blood + 1:10 Bleach 1.297 ± 0.080 
2I 1:2 Blood + 1:100 Bleach 1.873 ± 0.083 
2J 1:2 Blood + 1:1000 Bleach 1.840 ± 0.056 
2K 1:10 Blood + Neat Bleach Undet. 
0.401 ± 0.024 
(1:10 Blood) 
2L 1:10 Blood + 1:2 Bleach Undet. 
2M 1:10 Blood + 1:10 Bleach 0.001 ± 0.001 
2N 1:10 Blood + 1:100 Bleach 0.571 ± 0.035 
2O 1:10 Blood + 1:1000 Bleach 0.459 ± 0.019 
2P 1:100 Blood + Neat Bleach Undet. 
0.062 ± 0.008 
(1:100 Blood) 
2Q 1:100 Blood + 1:2 Bleach Undet. 
2R 1:100 Blood + 1:10 Bleach Undet. 
2S 1:100 Blood + 1:100 Bleach Undet. 
2T 1:100 Blood + 1:1000 Bleach 0.055 ± 0.011 
2U 1:1000 Blood + Neat Bleach Undet. 
0.003 ± 0.001 
(1:1000 Blood) 
2V 1:1000 Blood + 1:2 Bleach Undet. 
2W 1:1000 Blood + 1:10 Bleach Undet. 
2X 1:1000 Blood + 1:100 Bleach Undet. 
2Y 1:1000 Blood + 1:1000 Bleach Undet. 
 
 During the quantification process, the Ct values for the IPC analyzed alongside each of 
the samples in Set 2 were recorded and can be viewed with the quantification results in Appendix 
B. These values indicate whether there are increased, decreased, or similar levels of inhibition 
present in these bleach-treated samples when compared with the untreated, control samples of 
the same dilution of blood. The IPC Ct values for each of the three replicates of each 
blood/bleach mixture were averaged together and compared to the average IPC results from the 
control samples. The following graphs in Figure 14 illustrate that the average IPC result for 
every single bleach-treated sample was consistently lower than that of the corresponding control 
sample, with only two exceptions. The average IPC result for samples containing 1:10 blood 
treated with 1:10 bleach was 0.07 cycles higher than the control, while the average IPC value for 
1:100 blood/1:1000 bleach samples was 0.12 cycles higher than that of the control. 



















The electropherograms generated during the final step of analysis for Sample Set 2 were 
each given two scores, just as the Set 1 samples, using the same scoring system described 
previously. These two sets of scores are reported for each individual sample in Appendix C, 
while the average number of alleles called and the average number of balanced heterozygous loci 
for each of the mixtures is reported in Table 7. 
Figure 14. Average IPC Ct results for Sample Set 2 compared to the corresponding controls. Each graph displays the 
average IPC Ct results for each blood dilution. The red line on each graph illustrates the average IPC Ct value for the 
corresponding control blood dilution. The graphs show that the average IPC results reported for the treated samples in Set 2 
were consistently lower than those of the controls across all samples, with the exception of 1:10 blood/1:10 bleach samples 
and 1:100 blood/1:1000 bleach samples. 




Table 7: Average Genetic Profile Scores for Sample Set 2 




Average Number of 
Heterozygous Loci 
Over 50% 
2A Neat Blood + Neat Bleach 28 ± 0 12 ± 0 
2B Neat Blood + 1:2 Bleach 28 ± 0 12 ± 0 
2C Neat Blood + 1:10 Bleach 28 ± 0 12 ± 0 
2D Neat Blood + 1:100 Bleach 28 ± 0 12 ± 0 
2E Neat Blood + 1:1000 Bleach 28 ± 0 12 ± 0 
2F 1:2 Blood + Neat Bleach 0 ± 0 0 ± 0 
2G 1:2 Blood + 1:2 Bleach 28 ± 0 12 ± 0 
2H 1:2 Blood + 1:10 Bleach 28 ± 0 12 ± 0 
2I 1:2 Blood + 1:100 Bleach 28 ± 0 12 ± 0 
2J 1:2 Blood + 1:1000 Bleach 28 ± 0 12 ± 0 
2K 1:10 Blood + Neat Bleach 0 ± 0 0 ± 0 
2L 1:10 Blood + 1:2 Bleach 0 ± 0 0 ± 0 
2M 1:10 Blood + 1:10 Bleach 0.33 ± 0.58 0 ± 0 
2N 1:10 Blood + 1:100 Bleach 28 ± 0 12 ± 0 
2O 1:10 Blood + 1:1000 Bleach 28 ± 0 12 ± 0 
2P 1:100 Blood + Neat Bleach 0 ± 0 0 ± 0 
2Q 1:100 Blood + 1:2 Bleach 0 ± 0 0 ± 0 
2R 1:100 Blood + 1:10 Bleach 0 ± 0 0 ± 0 
2S 1:100 Blood + 1:100 Bleach 0 ± 0 0 ± 0 
2T 1:100 Blood + 1:1000 Bleach 28 ± 0 12 ± 0 
2U 1:1000 Blood + Neat Bleach 0 ± 0 0 ± 0 
2V 1:1000 Blood + 1:2 Bleach 0 ± 0 0 ± 0 
2W 1:1000 Blood + 1:10 Bleach 0 ± 0 0 ± 0 
2X 1:1000 Blood + 1:100 Bleach 0 ± 0 0 ± 0 
2Y 1:1000 Blood + 1:1000 Bleach 0 ± 0 0 ± 0 
 
These average results from the final genetic profiles generated from samples in Set 2 were 
compared to the average values from the appropriate control samples. Those comparisons are 
presented graphically in Figures 15 and 16. 
 
 

















It was also notable that for each of the three replicates (2A1, 2A2, and 2A3) of mixture 
2A (neat blood + neat bleach), the electropherograms showed significant numbers of artifacts, 
such as pull-up and minus-A peaks. The peak heights for these three samples were also 
significantly higher than any of the other samples processed in Sample Set 2 or the control 
Figure 15. Average number of alleles present in profiles for Sample Set 2 vs. controls. This graph 
illustrates the level of allelic dropout present in each blood/bleach combination in the dilution series. The 
corresponding control sample for each blood dilution is depicted in dark blue as the first bar at each blood 
dilution. 
Figure 16. Average number of balanced heterozygous loci in profiles for Sample Set 2 vs. controls.  
This graph illustrates balance of peak height ratios present in each blood/bleach combination in the dilution 
series. The corresponding control sample for each blood dilution is depicted in dark blue as the first bar at 
each blood dilution. 




samples of Set 1. This indicates that the amount of template DNA added at the beginning of the 
PCR process was too high, which leads to the conclusion that the quantification results reported 
for these three samples were lower than the amount of DNA actually present. This could be the 
result of DNA damage inflicted by the bleach that specifically affected the section of DNA 
amplified by the quantification kit, but did not affect the loci amplified by the Identifiler Plus® 
kit. All three replicates of the reagent blank for Sample Set 2 (RB2A, RB2B, and RB2C) 
performed as expected. The blanks showed no detectable quantification value and had no peaks 
above the analytical threshold on the electropherograms. Both the positive and negative 
amplification controls also performed as expected. 
4.3 Samples Treated with Lysol® Multi-Surface All-Purpose Cleaner 
 
 Experimental Sample Set 3 contained samples of each of the five dilutions of blood 
combined with each one of the five dilutions of Lysol® Multi-Surface All-Purpose Cleaner. Each 
blood/Lysol® mixture was then extracted in triplicate resulting in 75 individual samples being 
analyzed. A reagent blank containing only undiluted Lysol® and ultrapure, deionized water was 
also extracted in triplicate alongside the Set 3 samples for a total of 78 samples. Based solely 
upon visual inspection, the samples containing both neat blood and 1:2 blood did not display any 
visible changes regardless of what dilution of Lysol® was added to the sample. However, in 
multiple samples containing more dilute blood, the liquid changed dramatically from a bright 
red, as in the control samples, to a dark green solution upon the addition of Lysol®. These 
differences can be seen Figure 17. 
 




The quantification results from these 
samples were recorded and compared to the 
control samples for each blood dilution. The 
average quantification values for each Set 3 
mixture, as well as the average values for 
each corresponding control sample, are 
reported below in Table 8, while the raw 
quantification data for each individual 
sample is located in Appendix B. The 
quantification values for the Lysol®-treated 
samples were consistently higher for every 
dilution with the exception of one sample, 
3V, containing 1:1000 blood and 1:2 Lysol® 
(shown in red). 








3A Neat Blood + Neat Lysol® 7.023 ± 0.333 
5.840 ± 0.676 
(Neat Blood) 
3B Neat Blood + 1:2 Lysol® 6.767 ± 0.240 
3C Neat Blood + 1:10 Lysol® 6.890 ± 0.204 
3D Neat Blood + 1:100 Lysol® 6.773 ± 0.721 
3E Neat Blood + 1:1000 Lysol® 6.337 ± 1.315 
3F 1:2 Blood + Neat Lysol® 2.167 ± 0.042 
1.703 ± 0.135 
(1:2 Blood) 
3G 1:2 Blood + 1:2 Lysol® 2.253 ± 0.035 
3H 1:2 Blood + 1:10 Lysol® 1.917 ± 0.544 
3I 1:2 Blood + 1:100 Lysol® 2.027 ± 0.075 
3J 1:2 Blood + 1:1000 Lysol® 2.130 ± 0.118 
Figure 17. Examples of physical changes between control and 
Lysol®-treated samples. Control sample 1C (upper left)- 1:10 
blood dilution vs. Sample 3K (upper right)- 1:10 blood mixed with 
neat Lysol®; Control sample 1D (lower left)- 1:100 blood dilution 
vs. Samples 3P and 3Q (lower right)- 1:100 blood mixed with neat 
Lysol® and 1:2 Lysol®, respectively. 











3K 1:10 Blood + Neat Lysol® 1.163 ± 0.937 
0.401 ± 0.024 
(1:10 Blood) 
3L 1:10 Blood + 1:2 Lysol® 0.696 ± 0.030 
3M 1:10 Blood + 1:10 Lysol® 0.687 ± 0.024 
3N 1:10 Blood + 1:100 Lysol® 0.571 ± 0.020 
3O 1:10 Blood + 1:1000 Lysol® 0.608 ± 0.028 
3P 1:100 Blood + Neat Lysol® 0.101 ± 0.005 
0.062 ± 0.008 
(1:100 Blood) 
3Q 1:100 Blood + 1:2 Lysol® 0.100 ± 0.015 
3R 1:100 Blood + 1:10 Lysol® 0.088 ± 0.028 
3S 1:100 Blood + 1:100 Lysol® 0.066 ± 0.011 
3T 1:100 Blood + 1:1000 Lysol® 0.063 ± 0.007 
3U 1:1000 Blood + Neat Lysol® 0.007 ± 0.004 
0.003 ± 0.001 
(1:1000 Blood) 
3V 1:1000 Blood + 1:2 Lysol® 0.002 ± 0.001 
3W 1:1000 Blood + 1:10 Lysol® 0.006 ± 0.002 
3X 1:1000 Blood + 1:100 Lysol® 0.006 ± 0.003 
3Y 1:1000 Blood + 1:1000 Lysol® 0.007 ± 0.001 
 
The average quantification value for Sample 3K (1:10 Blood + 1:2 Lysol®) is 
considerably higher than the results for the other four Set 2 samples that contain 1:10 blood. This 
is due to one of the three replicates, sample 3K2, reporting a quantification value of 2.240. In an 
effort to determine if this abnormally high value was actually the correct DNA concentration for 
that sample, an additional replicate of sample 3K2, labeled as 3K2A, was amplified in the next 
step of analysis. This amount of this second replicate that was added to the amplification reaction 
was determined using an artificially calculated quantification value. This value, 0.625 ng 
DNA/µL, was obtained by averaging the quantification results of sample 3K1 and sample 3K3, 
which were both prepared from the same blood/Lysol® mixture as sample 3K2. Sample 3K2A, 
however, produced an electropherogram with multiple artifacts and extremely large peak heights, 
indicating that far too much DNA was added to the amplification reaction. This leads to the 
conclusion that the original elevated quantification value for sample 3K2 was accurate. 




The Ct values for the Quantifiler
® IPC for each of the samples in Set 3 were also recorded 
during the quantification process in order to monitor for the presence of inhibitors within the 
samples. These values can be found for each individual replicate in Appendix B with the rest of 
the Set 3 quantification data, while the averaged IPC Ct values for each of the blood/Lysol
® 
mixtures were compared to the average IPC values for analogous control samples. These 
comparisons were used to generate the graphs seen in Figure 18. The IPC values for the treated 
samples were consistently lower than those for the control samples in every combination of 












Figure 18. Average IPC Ct results for Sample Set 3 compared to the corresponding controls. Each graph displays the 
average IPC Ct results for each blood dilution. The red line on each graph illustrates the average IPC Ct value for the 
corresponding control blood dilution. The graphs show that the average IPC results reported for the treated samples in Set 3 
were consistently lower than those of the controls across all samples. 




After the quantification data for Sample Set 3 was used to accurately amplify each of the 
samples, they were processed on a 3500 Series® Genetic Analyzer. The resulting data was 
generated in the form of electropherograms which were then scored based upon the completeness 
and quality of the genetic profiles. These two separate scores for each individual profile can be 
found in Appendix C, while the average scores for each mixture in each of these categories is 
listed below in Table 9.  
Table 9: Average Genetic Profile Scores for Sample Set 3 
Sample Description 
Average Number 
of Alleles Present 
Average Number of 
Heterozygous Loci Over 50% 
3A Neat Blood + Neat Lysol® 28 ± 0 12 ± 0 
3B Neat Blood + 1:2 Lysol® 28 ± 0 12 ± 0 
3C Neat Blood + 1:10 Lysol® 28 ± 0 12 ± 0 
3D Neat Blood + 1:100 Lysol® 28 ± 0 12 ± 0 
3E Neat Blood + 1:1000 Lysol® 28 ± 0 12 ± 0 
3F 1:2 Blood + Neat Lysol® 28 ± 0 12 ± 0 
3G 1:2 Blood + 1:2 Lysol® 28 ± 0 12 ± 0 
3H 1:2 Blood + 1:10 Lysol® 28 ± 0 12 ± 0 
3I 1:2 Blood + 1:100 Lysol® 28 ± 0 12 ± 0 
3J 1:2 Blood + 1:1000 Lysol® 28 ± 0 12 ± 0 
3K 1:10 Blood + Neat Lysol® 28 ± 0 12 ± 0 
3L 1:10 Blood + 1:2 Lysol® 28 ± 0 12 ± 0 
3M 1:10 Blood + 1:10 Lysol® 28 ± 0 12 ± 0 
3N 1:10 Blood + 1:100 Lysol® 28 ± 0 12 ± 0 
3O 1:10 Blood + 1:1000 Lysol® 28 ± 0 12 ± 0 
3P 1:100 Blood + Neat Lysol® 28 ± 0 12 ± 0 
3Q 1:100 Blood + 1:2 Lysol® 28 ± 0 12 ± 0 
3R 1:100 Blood + 1:10 Lysol® 28 ± 0 12 ± 0 
3S 1:100 Blood + 1:100 Lysol® 28 ± 0 12 ± 0 
3T 1:100 Blood + 1:1000 Lysol® 28 ± 0 12 ± 0 
3U 1:1000 Blood + Neat Lysol® 23 ± 2.65 7 ± 2.65 
3V 1:1000 Blood + 1:2 Lysol® 19.67 ± 3.79 5.67 ± 2.08 
3W 1:1000 Blood + 1:10 Lysol® 24.67 ± 1.53 8.67 ± 0.58 
3X 1:1000 Blood + 1:100 Lysol® 22.33 ± 4.16 7 ± 3.61 
3Y 1:1000 Blood + 1:1000 Lysol® 22.67 ± 2.08 6.33 ± 0.58 
 




 The results reported for the genetic profiles generated for Sample Set 3 were compared to 
the results from the appropriate dilution of blood within the control sample set, and these 



















Figure 19. Average number of alleles present in profiles for Sample Set 3 vs. controls. This graph illustrates the level 
of allelic dropout present in each blood/Lysol® combination in the dilution series. The corresponding control sample for 
each blood dilution is depicted in dark blue as the first bar at each blood dilution. The treatment had no effect on the 
profile quality other than slightly lowered scores in the 1:1000 blood dilution when compared to the controls. 
Figure 20. Average number of balanced heterozygous loci in profiles for Sample Set 3 vs. controls. This graph 
illustrates the level of peak height balance in each blood/Lysol® combination in the dilution series. The corresponding 
control sample for each blood dilution is depicted in dark blue as the first bar at each blood dilution. The graph shows a 
similar pattern to the one in Figure 19 with only the most diluted blood showing any differences from the controls. 




Each of the three replicates of the reagent blank analyzed along with these samples showed no 
detectable quantification result and their respective electropherograms showed no visible peaks 
above the analytical threshold. Both the positive and negative amplification controls also 
displayed the expected results. 
4.4 Samples Treated with Resolve® Carpet Cleaner 
 
 The final set of experimental samples, Sample Set 4, consisted of blood samples treated 
with various dilutions of Resolve® Carpet Cleaner. This sample set included 3 replicates of each 
of the 25 blood/Resolve® mixtures as well as 3 replicates of a reagent blank sample containing 
undiluted Resolve® Carpet Cleaner and ultrapure, deionized water. The samples in this set 
underwent dramatic changes when treated with various dilutions of Resolve®. The most notable 
change was the production of a significant amount of gas, evidenced by the generation of a great 






Several of the samples also showed a dramatic color change, in many cases going from a bright 
red liquid to a completely clear, foamy solution after the addition of the cleaner. Examples of 
these changes are illustrated in Figure 22. 
Figure 21. Reaction when neat Resolve® Carpet Cleaner is added 
to liquid whole blood. The addition of Resolve® to liquid blood 
resulted in an immediate reaction that filled the entire 1.5 mL tube 
with red/brown foam. 












As with the previously reported sample sets, the average quantification result for each 
blood/Resolve® mixture was compared each complementary control sample and is listed in Table 
10. The complete quantification data for all replicates analyzed in Sample Set 4 is located in 
Appendix B. 









4A Neat Blood + Neat Resolve® 9.427 ± 1.736 
5.840 ± 0.676 
(Neat Blood) 
4B Neat Blood + 1:2 Resolve® 9.630 ± 0.465 
4C Neat Blood + 1:10 Resolve® 7.173 ± 0.440 
4D Neat Blood + 1:100 Resolve® 6.173 ± 0.454 
4E Neat Blood + 1:1000 Resolve® 7.150 ± 0.114 
Figure 22. Visible reactions 
between various dilutions 
of blood and Resolve® 
Carpet Cleaner. The red 
tubes contain a 1:2 blood 
dilution (top), a 1:10 blood 
dilution (center), and a 1:100 
blood dilution (bottom) with 
no treatment. The blue tubes 
contain the same blood 
dilutions in each row with 
neat Resolve® in the first 
tube, 1:2 Resolve® in the 
second tube, and 1:10 
Resolve in the third tube 
seen only in the last 
photograph. 












4F 1:2 Blood + Neat Resolve® 3.187 ± 0.268 
1.703 ± 0.135 
(1:2 Blood) 
4G 1:2 Blood + 1:2 Resolve® 3.027 ± 0.201 
4H 1:2 Blood + 1:10 Resolve® 2.327 ± 0.050 
4I 1:2 Blood + 1:100 Resolve® 1.807 ± 0.047 
4J 1:2 Blood + 1:1000 Resolve® 1.777 ± 0.106 
4K 1:10 Blood + Neat Resolve® 0.781 ± 0.145 
0.401 ± 0.024 
(1:10 Blood) 
4L 1:10 Blood + 1:2 Resolve® 0.712 ± 0.052 
4M 1:10 Blood + 1:10 Resolve® 0.619 ± 0.052 
4N 1:10 Blood + 1:100 Resolve® 0.504 ± 0.045 
4O 1:10 Blood + 1:1000 Resolve® 0.492 ± 0.013 
4P 1:100 Blood + Neat Resolve® 0.066 ± 0.009 
0.062 ± 0.008 
(1:100 Blood) 
4Q 1:100 Blood + 1:2 Resolve® 0.050 ± 0.021 
4R 1:100 Blood + 1:10 Resolve® 0.082 ± 0.004 
4S 1:100 Blood + 1:100 Resolve® 0.068 ± 0.002 
4T 1:100 Blood + 1:1000 Resolve® 0.053 ± 0.007 
4U 1:1000 Blood + Neat Resolve® 0.008 ± 0.007 
0.003 ± 0.001 
(1:1000 Blood) 
4V 1:1000 Blood + 1:2 Resolve® 0.010 ± 0.003 
4W 1:1000 Blood + 1:10 Resolve® 0.011 ± 0.002 
4X 1:1000 Blood + 1:100 Resolve® 0.010 ± 0.004 
4Y 1:1000 Blood + 1:1000 Resolve® 0.008 ± 0.001 
 
The first three dilutions of blood within Set 4 (Neat, 1:2, and 1:10 blood) all follow a similar 
pattern, in that, the samples with more concentrated Resolve® added (Neat, 1:2, and 1:10) all 
showed considerably higher concentrations of DNA present after the extraction process. This 















Collected simultaneously with the quantification data was the Ct value for the Internal 
PCR Control that was added to each sample during the quantification process to monitor for 
inhibition. These individual values are reported out in the quantification data located in 
Appendix B, while the average IPC Ct value for each blood dilution was compared to the average 
IPC for the appropriate control sample to generate the graphs that are displayed in Figure 24. The 
IPC Ct values do not appear to follow a discernable pattern within each dilution set; however, the 
IPC result for every sample containing undiluted Resolve® was consistently higher than the 
corresponding control IPC value regardless of the dilution of blood within the sample. 
 
 
Figure 23. Average quantification results for the first 3 dilutions of Sample Set 4 vs. control samples. The graphs 
show the increased amount of DNA extracted from blood samples treated with Resolve® Carpet Cleaner (red) vs. blood 
only samples (green). As the concentration of Resolve® in the samples increased, the amount of DNA recovered 
increased as well. 

















The final product of analysis for each sample was an electropherogram displaying the 
genetic profile. The quality of each of these electropherograms was translated to quantitative data 
using the scoring system described previously to record the number of allelic peaks present in the 
profile as well as the number of balanced heterozygous loci. This quantitative data is listed in its 
entirety in Appendix C, while the average values are listed in the following table. 
Figure 24. Average IPC Ct results for Sample Set 4 compared to the corresponding controls. Each graph displays the 
average IPC Ct results for each blood dilution. The green line on each graph illustrates the average IPC Ct value for the 
corresponding control blood dilution. The only discernable trend illustrated by the graphs is that every sample treated with 
undiluted Resolve® Carpet Cleaner reported an elevated IPC Ct value compared to the control, regardless of the dilution of 
blood in the sample. 





Table 11: Average Genetic Profile Scores for Sample Set 4 
Sample Description 
Average Number of 
Alleles Present 
Average Number of 
Heterozygous Loci Over 
50% 
4A Neat Blood + Neat Resolve® 28 ± 0 12 ± 0 
4B Neat Blood + 1:2 Resolve® 28 ± 0 12 ± 0 
4C Neat Blood + 1:10 Resolve® 28 ± 0 12 ± 0 
4D Neat Blood + 1:100 Resolve® 28 ± 0 12 ± 0 
4E Neat Blood + 1:1000 Resolve® 28 ± 0 12 ± 0 
4F 1:2 Blood + Neat Resolve® 28 ± 0 12 ± 0 
4G 1:2 Blood + 1:2 Resolve® 28 ± 0 12 ± 0 
4H 1:2 Blood + 1:10 Resolve® 28 ± 0 12 ± 0 
4I 1:2 Blood + 1:100 Resolve® 28 ± 0 12 ± 0 
4J 1:2 Blood + 1:1000 Resolve® 28 ± 0 12 ± 0 
4K 1:10 Blood + Neat Resolve® 28 ± 0 12 ± 0 
4L 1:10 Blood + 1:2 Resolve® 28 ± 0 12 ± 0 
4M 1:10 Blood + 1:10 Resolve® 28 ± 0 12 ± 0 
4N 1:10 Blood + 1:100 Resolve® 28 ± 0 12 ± 0 
4O 1:10 Blood + 1:1000 Resolve® 28 ± 0 12 ± 0 
4P 1:100 Blood + Neat Resolve® 0 ± 0 0 ± 0 
4Q 1:100 Blood + 1:2 Resolve® 28 ± 0 11.33 ± 0.58 
4R 1:100 Blood + 1:10 Resolve® 28 ± 0 12 ± 0 
4S 1:100 Blood + 1:100 Resolve® 28 ± 0 12 ± 0 
4T 1:100 Blood + 1:1000 Resolve® 28 ± 0 12 ± 0 
4U 1:1000 Blood + Neat Resolve® 1.33 ±  0 ± 0 
4V 1:1000 Blood + 1:2 Resolve® 18.33 ±  6.67 ± 0.58 
4W 1:1000 Blood + 1:10 Resolve® 28 ± 0 11.33 ± 1.15 
4X 1:1000 Blood + 1:100 Resolve® 28 ± 0 10.67 ± 1.15 
4Y 1:1000 Blood + 1:1000 Resolve® 28 ± 0 11.33 ± 1.15 
 
The data presented in Table 11 was compared to the corresponding data from the control 
samples. In order to visualize the differences present in the Resolve®-treated samples, the 

























 All three of the reagent blank replicates performed as expected throughout the analysis 
process, displaying no quantification results and showing no peaks tall enough to be called by the 
analysis software on any of the three electropherograms. The positive amplification control also 
Figure 25. Average number of alleles present in profiles for Sample Set 4 vs. controls. This graph illustrates the level 
of allelic dropout present in each blood/Resolve® combination in the dilution series. The corresponding control sample for 
each blood dilution is depicted in dark blue as the first bar at each blood dilution. The 1:100 and 1:1000 blood dilutions 
show almost complete profile dropout when treated with neat Resolve® and the 1:1000 showed moderate dropout with 1:2 
Resolve®.
Figure 26. Average number of balanced heterozygous loci in profiles for Sample Set 4 vs. controls. This graph 
illustrates the level of peak height balance in each blood/Resolve® combination in the dilution series. The corresponding 
control sample for each blood dilution is depicted in dark blue as the first bar at each blood dilution. Given the level of 
allelic dropout seen in the 1:100 blood/neat Resolve® and 1:1000 blood/neat Resolve® samples, the average peak height 
balance score was 0 for both sample types. 




displayed the expected results, while the negative control displayed no peaks, which indicates 
that there was no contamination of the amplification reagents by extraneous DNA. 




4. DISCUSSION AND CONCLUSIONS 
 
4.1 DNA Quantification 
 
 After collecting and comparing data from the quantification of the DNA extracted from 
each of the samples, the relationships between the control and experimental data were used to 
evaluate the performance of the Automate Express™/Prepfiler Express™ extraction method 
under each of the three experimental conditions. The efficiency of the extraction system was 
evaluated by comparing the amount of DNA recovered from treated samples to that recovered 
from controls. The ability of this automated system to remove PCR inhibitors from extracted 
DNA was judged using the results from the Internal PCR Control contained in the quantification 
kit. 
 The samples from Set 2 that were treated with Clorox® Bleach showed the most dramatic 
difference in the amount of DNA extracted when compared to the control samples. The change 
in average quantification values across the entire data set is shown in Figure 27. The amount of 
DNA recovered from the samples decreases dramatically if treated with bleach at either full or 
half strength.   
Figure 27. Average quantification values for the entirety of Sample Set 2. This graph is a 3-dimentional 
representation of the average amount of DNA recovered from each blood/bleach combination in set 3. It 
allows the visualization of the point in each dilution series when the most dramatic changes are seen. 




0.246739 0.180405 0.03198 0.389939 0.015188 1:1000
0.222432 0.137021 0.00231 0.000144 0.015188 1:100
0.072603 0.010949 8.83E‐06 0.000144 0.015188 1:10
0.000605 4.84E‐05 8.7E‐06 0.000144 0.015188 1:2
0.000168 2.6E‐05 8.7E‐06 0.000144 0.015188 neat











The variance between this data and the control set was tested for statistical significance 
using a single-factor ANOVA test. The ANOVA tests for the equality of means between two sets 
of data and reports a “p-value” which is either above or below the critical value (α) selected 
based upon the confidence level used. If the p-value is above the critical value, the means are 
statistically equal, and if the p-value is below α, the means are not equal (D'Agostino, Sullivan, 
& Beiser, 2006). The p-value for each of the blood/bleach combinations is presented below in 
Figure 28. The test applied a 95% confidence level and the individual p-values are labeled in red 
if they are below 0.05, indicating the treated sample differed significantly from the 
corresponding control with regards to DNA quantification results. The green labels are given to 
samples that have a p-value above 0.05, meaning the data from the treated sample is not 
statistically different from the control data. In order to more easily correlate these statistical 
results with the trends in quantification values for Sample Set 2, they are presented alongside the 






Figure 28. Statistical significance of variance of quantification data between control samples and bleach-treated samples. 
The chart on the left displays the p-value generated by conducting an ANOVA test between the control and the treated samples 
within each blood/bleach combination. The green squares indicate a p-value > 0.05 meaning the quantification values were not 
statistically different than the control data, while the red squares contain p-values < 0.05 meaning the treated samples are 
significantly different than the controls. This statistical data can then be compared to the changes in quantification values that 
are displayed in the graph to the right. Each red or green square corresponds with a data point on the graph where the blood 
dilution and bleach dilution lines intersect. 




It is both visibly and statistically clear that the presence of bleach in a blood sample 
decreases the amount of amplifiable DNA that is recovered. This effect is more pronounced in 
the samples treated with more concentrated bleach. However, the current DNA quantification 
methods do not make a distinction between samples that do not contain DNA and samples that 
contain DNA that is degraded to the point that real-time PCR is not possible. Because of this 
limitation, the quantification data alone does not determine conclusively whether or not the 
Automate Express™ system successfully extracted DNA from samples treated with bleach. 
 The data generated from the DNA quantification of both Sample Set 3, samples treated 
with Lysol®, and Sample Set 4, samples treated with Resolve®, display similar overall results in 
relation to the corresponding control data. Figure 29 below presents the average DNA 










Figure 29. Average quantification values for Sample Sets 3 and 4 vs. control samples. These 3-D surface graphs display the 
changes in DNA concentration extracted across the entire sample set for Set 3 (top left), Set 4 (bottom left), and the control 
samples (right). Comparing each of the graphs on the left to the controls shows that both Set 3 and Set 4 follow a similar pattern 
to the controls, but Sample Set 4 shows an increased amount of DNA recovered from the samples containing high concentrations 
of both blood and Resolve®. 




Graphically, the data from both Set 3 and Set 4 display little variance from the control 
data. The samples that show the most noticeable difference are those that contain a higher 
amount of both blood and each of the cleaners, particularly the neat blood/neat Resolve® 
samples. However, rather than showing a reduced amount of DNA extracted due to interference 
from the cleaning products as expected, these treated samples actually resulted in more DNA 
being isolated from the blood samples. With regards to the samples containing high amounts of 
hydrogen peroxide and blood, this is likely due to the heme compound in the red blood cells, a 
known PCR inhibitor, being catalyzed by the hydrogen peroxide. Quantitatively, both the 
samples treated with Lysol® and the samples treated with Resolve® reported higher 
concentrations of DNA extracted than the corresponding control samples at every blood/cleaner 
ratio with one exception in each set. For all of the ratios tested in both experimental sets, only 
two ratios had average DNA quantification values that were lower than the controls, 1:1000 
blood/1:2 Lysol® and 1:100 blood/1:2 Resolve®. However, after applying a single-factor 
ANOVA test to compare these results with the control data, it was determined that the variance 
was not a statistically significant one. To summarize the quantification data as a whole for these 
two experimental sets, the treated samples resulted in a DNA concentration that was higher than 
that of the controls in the majority of samples, and even those samples that did not show an 
improvement in the amount of DNA extracted reported data that was statistically similar to the 
controls. Overall, this leads to the conclusion that with regards to amount of DNA recovered, the 
extraction methodology performs at least as well, if not more efficiently, under each of these two 
treatment conditions. 
 




5.2 Internal PCR Control Results 
 
 The Ct results for the Internal PCR Control (IPC) included in each quantification reaction 
were used as an indicator of the presence of substances that inhibit the PCR process, as described 
in Section 4.1. The IPC results for the samples from Set 2 that were treated with Clorox® Regular 
Bleach were consistently lower for every blood/bleach ratio than they were for the corresponding 
untreated control sample with the exception of the two samples described in Section 4.2. As both 
of these samples displayed IPC results that were only slightly elevated and contained diluted 
bleach, it is more likely that these results were due to non-uniform sampling of the blood 
dilutions rather than the effects of the bleach treatment. These results indicate that not only is the 
Automate Express® system not negatively impacted by the addition of bleach to a blood sample, 
the presence of inhibitors is actually reduced after adding bleach. Unfortunately, the limits of the 
IPC technology do not allow one to determine if the inhibitors were removed more effectively by 
the extraction technology, or if the inhibiting substances were simply destroyed by the bleach 
prior to extraction. Regardless, the results do show definitively that bleach does not reduce the 
ability of the Automate Express™/Prepfiler Express™ system to remove inhibitors from a 
sample.  
 The IPC Ct results for the Lysol
®-treated samples from Set 3 resembled those of Set 2; 
however, in this sample set the average IPC values were lower in the treated samples than the 
controls for every single sample without exception. This leads to a similar conclusion as that 
reached for Sample Set 2, that although the lowered IPC values cannot be attributed definitively 
to an increased effectiveness in the extraction system, the system is not negatively impacted in 
general by the presence of Lysol® in liquid blood samples. 




 The effects of Resolve® on the IPC Ct results for Sample Set 4 differ from those of the 
previous two sample sets. The average IPC values for samples containing neat Resolve® are all 
elevated when compared to the control data, regardless of the dilution of blood present in the 
sample. These results support the conclusions of Akane’s study discussed in Section 2.3.3 which 
determined that hydrogen peroxide, which is the active ingredient in Resolve® Carpet Cleaner, 
can inhibit PCR in forensic samples (Akane, 1996). The majority of the samples containing 
dilutions of Resolve® have IPC values that are similar to the control samples, differing only 
slightly in either direction and without a discernable trend. This data indicates that diluted 
Resolve® has no observable negative impact upon the efficiency of the Automate Express® 
system; however, the system is unable to completely remove the inhibitory compounds present in 
full strength Resolve®, regardless of the concentration of blood present in the sample. 
5.3 Genetic Profile Quality 
 
 The evaluation of the quality of genetic profiles obtained from samples treated with 
Clorox® Bleach was completed by scoring the electropherograms generated with regards to the 
number of alleles present, with a maximum of 28, and the number of balanced heterozygous loci, 
with a maximum of 12. The analysis of the data from this sample set was relatively 
straightforward as each of the samples produced either a complete balanced profile, or they 
generated no useful profile whatsoever. The only exception to this was Sample 2M1 that 
generated an electropherogram with only one allele called. In order to compare the allelic 
dropout scores across the entire data set, the ratio of percent blood to percent bleach in each 
sample, which ranged from 0.001 to 1000, was converted to a logarithmic value and graphed in 
relation to each sample’s dropout score, as seen in Figure 30. 
 




Figure 30 clearly illustrates the critical point at which the profiles changed from a 
complete profile to no useful profile recovered at all. This point falls directly on the y-axis in the 
graph which indicates a log(%blood/%bleach) value of 0. When this value is converted back to a 
ratio it is equal to 1:1 ratio of blood to bleach. This indicates that the concentration of blood must 
be higher than that of bleach in a sample in order to obtain a DNA profile. In order for this data 
trend to be useful to a crime scene agent, it can be correlated to the physical appearance of the 
samples. In general terms, the samples which produced full genetic profiles were those that were 
visibly red or dark brown in color, while the samples that turned completely clear or clear with a 
yellow precipitate produced no genetic information. It should be noted that, while it was not the 
topic of this research, these results indicate that the common decontamination procedures 
employed in forensic DNA laboratories, typically using 1:10 bleach dilutions, may not be 
sufficient to destroy DNA after handling liquid blood. 
Figure 30. Allelic dropout scores for bleach-treated samples. This graph presents the average allelic dropout scores for 
samples treated with bleach based upon the (%blood)/(%bleach) ratio in each sample. When the ratios are converted to a 
logarithmic scale, the graph clearly depicts the critical point at which the samples go from a full profile (28 alleles) to profiles 
with no alleles called. This point is located directly at the vertical axis where the log(%blood/%bleach) = 0. This translates to 
a 1:1 blood:bleach ratio. 




The genetic profiles generated from the Lysol®-treated samples in Sample Set 3 showed 
no signs of allelic dropout and were balanced at all 12 heterozygous loci in all replicates of 
samples containing neat, 1:2, 1:10, and 1:100 blood. The samples with the most diluted blood 
showed slight variation with each dilution of Lysol® added, however, all of the samples still 
generated partial profiles with anywhere from 18-27 alleles present and there was no discernable 
trend with regards to the strength of the Lysol® in each sample. This does not differ dramatically 
from the results seen in the 3 control sample replicates with 1:1000 blood, and with 
quantification levels ranging from only 0.002-0.011 ng/µL of DNA these somewhat variable 
results are not surprising. Overall, treatment with Lysol® did not have a measurable negative 
impact on genetic profile quality in any blood/cleaner ratio, even those that showed dramatic 
changes in physical appearance. 
The quality scores for the genetic profiles produced from Sample Set 4, those treated with 
Resolve® Carpet Cleaner, give more evidence to the conclusion that the hydrogen peroxide is 
inhibiting PCR in these samples. The samples containing neat, 1:2, and 1:10 blood all generated 
full, balanced profiles with no dropout, however, the 1:100 and 1:1000 blood samples all showed 
a drastic difference from the controls when treated with neat Resolve®. All three of the 1:100 
blood/neat Resolve® samples produced no profile whatsoever, and only one of the replicates of 
1:1000 blood/neat Resolve® generated even a partial profile, that profile having only 4 alleles 
present. Given that the average quantification values for these samples were higher than the 
corresponding controls, it can be concluded that the inability to generate useful profiles from the 
samples is due to PCR inhibition caused by the hydrogen peroxide in Resolve®. Unfortunately, 
these results cannot be correlated directly to the physical appearance of the sample as several of 
the samples with more diluted Resolve® generated full genetic profiles, but looked very similar 




to the completely inhibited samples. In crime scene situations dealing with minute amounts of 
blood, if crime scene personnel suspect that the scene was cleaned with a hydrogen peroxide-
based cleaner, they should be prepared for possible negative consequences with downstream 
DNA analysis. Further research investigating this property of hydrogen peroxide with regards to 




 The goals of this research were two-fold. The first was to evaluate the performance of the 
Automate Express™ Forensic DNA Extraction System and the Prepfiler Express™ Forensic 
DNA Extraction Kit when extracting DNA from blood samples treated with three different 
common cleaning products. The second goal was to evaluate the impact that these three types of 
cleaners have on the forensic DNA analysis process with regards to the quality of the genetic 
profile that is generated. With regards to Clorox® Regular Bleach-treated samples, the Automate 
Express™ system extracted lower amounts of DNA in the majority of samples than what was 
extracted from corresponding control samples, however, it is not possible to conclusively 
determine if this was due to lowered effectiveness of the extraction system or due to severe 
degradation of the DNA by the bleach to the point that it could not be quantified. The IPC results 
showed that the automated system was able to successfully remove any inhibitors that may have 
been present in the bleach-treated samples. In the case of the samples that were treated with 
Lysol® Multi-Surface All-Purpose Cleaner, the Automate Express™ system effectively extracted 
DNA in quantities similar to or greater than the untreated samples, and the DNA extracted was 
effectively purified by the system to remove PCR inhibitors. Finally, the automated system was 
able to extract high amounts of DNA from samples treated with Resolve® Carpet Cleaner, but it 




was unable to completely remove the PCR inhibiting hydrogen peroxide from samples 
containing full strength Resolve® which led to downstream amplification problems in more 
diluted blood samples. Overall, the Automate Express™ Forensic DNA Extraction System and 
the Prepfiler Express™ Forensic DNA Extraction Kit performed well in the presence of these 
chemical contaminants with regards to the amount and quality of DNA extracted. 
 With regards to the impact that these cleaning chemicals have on the ability to generate a 
useful genetic profile, bleach had by far the most detrimental impact on the profiles. If a sample 
is collected that contains a higher concentration of bleach than blood, the likelihood of obtaining 
any useful information at all is very remote. In physical terms, if the blood at a crime scene has 
been cleaned with bleach to the point that it is no longer visible to the naked eye, it is unlikely 
that investigators should expect a useable profile. In the other extreme, Lysol® Multi-Surface 
All-Purpose Cleaner has no negative impact on the DNA in blood samples at all. If investigators 
have reason to believe a crime scene has been cleaned with a product containing quaternary 
ammonium compounds, they can still reasonably expect useful profiles to be obtained from 
blood evidence present despite how drastically the physical appearance of said blood has been 
altered. Lastly, the samples treated with the hydrogen peroxide-based Resolve® Carpet Cleaner 
gave results indicating that larger amounts of blood should still produce full profiles even after 
being cleaned with this product. Small amounts of blood, however, that are treated with larger 
volumes of Resolve® could be severely inhibited to the point that no useful genetic information 
can be obtained. Bearing this in mind, crime scene personnel should clearly communicate to the 
laboratory analyst that a hydrogen peroxide-based product was used to clean blood evidence, so 
that the analyst will be prepared to take additional steps to deal with possible PCR inhibition in 
the sample. These results provide a scientific foundation that both crime scene and forensic 




laboratory personnel can use to make decisions and manage expectations regarding the collection 
and processing of evidence that has been contaminated with cleaning products. Further research 
in this area should include other types of chemical contaminants that might be used in an attempt 
to destroy DNA; it should also study other types of biological samples in addition to blood.
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APPENDIX A: Description of Samples 
 
Sample Set 1: Control Samples 
Sample (Replicates) Description 
1A (1A1, 1A2, 1A3) Control- Neat Blood 
1B (1B1, 1B2, 1B3) Control- 1:2 Blood 
1C (1C1, 1C2, 1C3) Control- 1:10 Blood 
1D (1D1, 1D2, 1D3) Control- 1:100 Blood 
1E (1E1, 1E2, 1E3) Control- 1:1000 Blood 
RB1 PBS + Ultrapure H2O 
 
Sample Set 2: Samples Treated with Clorox® Regular Bleach 
Sample Description 
2A (2A1, 2A2, 2A3) Neat Blood + Neat Bleach 
2B (2B1, 2B2, 2B3) Neat Blood + 1:2 Bleach 
2C (2C1, 2C2, 2C3) Neat Blood + 1:10 Bleach 
2D (2D1, 2D2, 2D3) Neat Blood + 1:100 Bleach 
2E (2E1, 2E2, 2E3) Neat Blood + 1:1000 Bleach 
2F (2F1, 2F2, 2F3) 1:2  Blood + Neat Bleach 
2G (2G1, 2G2, 2G3) 1:2  Blood + 1:2 Bleach 
2H (2H1, 2H2, 2H3) 1:2  Blood + 1:10 Bleach 
2I (2I1, 2I2, 2I3) 1:2  Blood + 1:100 Bleach 
2J (2J1, 2J2, 2J3) 1:2  Blood + 1:1000 Bleach 
2K (2K1, 2K2, 2K3) 1:10  Blood + Neat Bleach 
2L (2L1, 2L2, 2L3) 1:10  Blood + 1:2 Bleach 
2M (2M1, 2M2, 2M3) 1:10  Blood + 1:10 Bleach 
2N (2N1, 2N2, 2N3) 1:10  Blood + 1:100 Bleach 
2O (2O1, 2O2, 2O3) 1:10  Blood + 1:1000 Bleach 
2P (2P1, 2P2, 2P3) 1:100  Blood + Neat Bleach 
2Q (2Q1, 2Q2, 2Q3) 1:100  Blood + 1:2 Bleach 
2R (2R1, 2R2, 2R3) 1:100  Blood + 1:10 Bleach 
2S (2S1, 2S2, 2S3) 1:100  Blood + 1:100 Bleach 
2T (2T1, 2T2, 2T3) 1:100  Blood + 1:1000 Bleach 
2U (2U1, 2U2, 2U3) 1:1000  Blood + Neat Bleach 
2V (2V1, 2V2, 2V3) 1:1000  Blood + 1:2 Bleach 
2W (2W1, 2W2, 2W3) 1:1000  Blood + 1:10 Bleach 
2X (2X1, 2X2, 2X3) 1:1000  Blood + 1:100 Bleach 
2Y (2A1, 2A2, 2Y3) 1:1000  Blood + 1:1000 Bleach 
RB2 (RB2A, RB2B, RB2C) Neat Bleach + Ultrapure H2O 
 




Sample Set 3: Samples Treated with Lysol® Multi-Surface All-Purpose Cleaner  
Sample (Replicates) Description 
3A (3A1, 3A2, 3A3) Neat Blood + Neat Lysol 
3B (3B1, 3B2, 3B3) Neat Blood + 1:2 Lysol 
3C (3C1, 3C2, 3C3) Neat Blood + 1:10 Lysol 
3D (3D1, 3D2, 3D3) Neat Blood + 1:100 Lysol 
3E (3E1, 3E2, 3E3) Neat Blood + 1:1000 Lysol 
3F (3F1, 3F2, 3F3) 1:2  Blood + Neat Lysol 
3G (3G1, 3G2, 3G3) 1:2  Blood + 1:2 Lysol 
3H (3H1, 3H2, 3H3) 1:2  Blood + 1:10 Lysol 
3I (3I1, 3I2, 3I3) 1:2  Blood + 1:100 Lysol 
3J (3J1, 3J2, 3J3) 1:2  Blood + 1:1000 Lysol 
3K (3K1, 3K2, 3K3) 1:10  Blood + Neat Lysol 
3L (3L1, 3L2, 3L3) 1:10  Blood + 1:2 Lysol 
3M (3M1, 3M2, 3M3) 1:10  Blood + 1:10 Lysol 
3N (3N1, 3N2, 3N3) 1:10  Blood + 1:100 Lysol 
3O (3O1, 3O2, 3O3) 1:10  Blood + 1:1000 Lysol 
3P (3P1, 3P2, 3P3) 1:100  Blood + Neat Lysol 
3Q (3Q1, 3Q2, 3Q3) 1:100  Blood + 1:2 Lysol 
3R (3R1, 3R2, 3R3) 1:100  Blood + 1:10 Lysol 
3S (3S1, 3S2, 3S3) 1:100  Blood + 1:100 Lysol 
3T (3T1, 3T2, 3T3) 1:100  Blood + 1:1000 Lysol 
3U (3U1, 3U2, 3U3) 1:1000  Blood + Neat Lysol 
3V (3V1, 3V2, 3V3) 1:1000  Blood + 1:2 Lysol 
3W (3W1, 3W2, 3W3) 1:1000  Blood + 1:10 Lysol 
3X (3X1, 3X2, 3X3) 1:1000  Blood + 1:100 Lysol 
3Y (3A1, 3A2, 3Y3) 1:1000  Blood + 1:1000 Lysol 











Sample Set 4: Samples Treated with Resolve® Carpet Cleaner 
Sample (Replicates) Description 
4A (4A1, 4A2, 4A3) Neat Blood + Neat Resolve 
4B (4B1, 4B2, 4B3) Neat Blood + 1:2 Resolve 
4C (4C1, 4C2, 4C3) Neat Blood + 1:10 Resolve 
4D (4D1, 4D2, 4D3) Neat Blood + 1:100 Resolve 
4E (4E1, 4E2, 4E3) Neat Blood + 1:1000 Resolve 
4F (4F1, 4F2, 4F3) 1:2  Blood + Neat Resolve 
4G (4G1, 4G2, 4G3) 1:2  Blood + 1:2 Resolve 
4H (4H1, 4H2, 4H3) 1:2  Blood + 1:10 Resolve 
4I (4I1, 4I2, 4I3) 1:2  Blood + 1:100 Resolve 
4J (4J1, 4J2, 4J3) 1:2  Blood + 1:1000 Resolve 
4K (4K1, 4K2, 4K3) 1:10  Blood + Neat Resolve 
4L (4L1, 4L2, 4L3) 1:10  Blood + 1:2 Resolve 
4M (4M1, 4M2, 4M3) 1:10  Blood + 1:10 Resolve 
4N (4N1, 4N2, 4N3) 1:10  Blood + 1:100 Resolve 
4O (4O1, 4O2, 4O3) 1:10  Blood + 1:1000 Resolve 
4P (4P1, 4P2, 4P3) 1:100  Blood + Neat Resolve 
4Q (4Q1, 4Q2, 4Q3) 1:100  Blood + 1:2 Resolve 
4R (4R1, 4R2, 4R3) 1:100  Blood + 1:10 Resolve 
4S (4S1, 4S2, 4S3) 1:100  Blood + 1:100 Resolve 
4T (4T1, 4T2, 4T3) 1:100  Blood + 1:1000 Resolve 
4U (4U1, 4U2, 4U3) 1:1000  Blood + Neat Resolve 
4V (4V1, 4V2, 4V3) 1:1000  Blood + 1:2 Resolve 
4W (4W1, 4W2, 4W3) 1:1000  Blood + 1:10 Resolve 
4X (4X1, 4X2, 4X3) 1:1000  Blood + 1:100 Resolve 
4Y (4A1, 4A2, 4Y3) 1:1000  Blood + 1:1000 Resolve 
RB4 (RB4A, RB4B, RB4C) Neat Resolve + Ultrapure H2O 
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APPENDIX C: Genetic Profile Quality Scores 
 
Sample Set 1 
Sample 
Name 
# of Peaks # of HZ Loci over 50% Notes 
1A1 28 12 Pull-up in TPOX and D18. 
1A2 28 12   
1A3 28 12   
1B1 28 12 OL allele at FGA. 511 RFU. 
1B2 28 12 Pull-up in D18. 
1B3 28 12   
1C1 28 12   
1C2 28 12   
1C3 28 12   
1D1 28 12   
1D2 28 12   
1D3 28 12   
1E1 27 9 D3: 43.7%, D2: 50.0%, FGA: 22.3 drop out 
1E2 25 8 D13: 44.1%, D18: 13.2 drop out, Amel: Y drop out, D5: 
14 drop out 
1E3 24 9 Amel: X and Y drop out, D5: 12 drop out, FGA: 23 drop 
out 
RB1 0 0   
 
Sample Set 2 
Sample 
Name 
# of Peaks # of HZ Loci over 50% Notes 
2A1 28 12 
Multiple artifacts (pull-up, minus-a, etc.) due to excess 
DNA. 
2A2 28 12 
Multiple artifacts (pull-up, minus-a, etc.) due to excess 
DNA. 
2A3 28 12 
Multiple artifacts (pull-up, minus-a, etc.) due to excess 
DNA. 
2B1 28 12 Pull-up at FGA. 
2B2 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2B3 28 12 Pull-up at TPOX, D18, and FGA. 
2C1 28 12 Pull-up at FGA. 
2C2 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2C3 28 12 Pull-up at D19, TPOX, D18, and FGA. 






# of Peaks # of HZ Loci over 50% Notes 
2D1 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2D2 28 12 
2D3 28 12 Pull-up at FGA. 
2E1 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2E2 28 12 Pull-up at D19, vWA, TPOX, D18, and FGA. 
2E3 28 12 Pull-up at D19, D18, D5, and FGA. 
2F1 0 0 Spike at 285.50 bp in red and blue channels. 
2F2 0 0 Spike at 130.92 bp in blue, green, and red channels. 
2F3 0 0 
2G1 28 12 
2G2 28 12 Pull-up at FGA. 
2G3 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2H1 28 12 Pull-up at TPOX. 
2H2 28 12 
2H3 28 12 Spike in all channels at 176.91 bp. 
2I1 28 12 Pull-up at D19, TPOX, and D18. 
2I2 28 12 
2I3 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2J1 28 12 Pull-up at D19, vWA, TPOX, D18, and FGA. 
2J2 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2J3 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2K1 0 0 
2K2 0 0 
2K3 0 0 Spike at 205.73. 
2L1 0 0 
2L2 0 0 
2L3 0 0 
2M1 1 0 Y allele at Amel only. 






# of Peaks # of HZ Loci over 50% Notes 
2M2 0 0 
2M3 0 0 
2N1 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2N2 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2N3 28 12 
2O1 28 12 Pull-up at D19, D18, and FGA. 
2O2 28 12 Pull-up at D19, TPOX, D18, and FGA. 
2O3 28 12 Pull-up at D19 and D18. 
2P1 0 0 
2P2 0 0 
2P3 0 0 
2Q1 0 0 
2Q2 0 0 
2Q3 0 0 Spike at ~263 bp in red and yellow channels. 
2R1 0 0 
2R2 0 0 
2R3 0 0 
2S1 0 0 
2S2 0 0 Spike at 242.56 bp in blue, green and red channels. 
2S3 0 0 
2T1 28 12 
Spikes at 192.5 bp in red and ~247.8 bp in blue, green, 
and red channels. 
2T2 28 12 Pull-up at D19 and D18. 
2T3 28 12 
2U1 0 0 
2U2 0 0 
2U3 0 0 
2V1 0 0 
2V2 0 0 






# of Peaks # of HZ Loci over 50% Notes 
2V3 0 0 
2W1 0 0 
2W2 0 0 
2W3 0 0 
2X1 0 0 
2X2 0 0 
2X3 0 0 
2Y1 0 0 
2Y2 0 0 
2Y3 0 0 
RB2A 0 0 
RB2B 0 0 
RB2C 0 0 
 
Sample Set 3 
Sample 
Name 
# of Peaks # of HZ Loci over 50% Notes 
3A1 28 12   
3A2 28 12   
3A3 28 12   
3B1 28 12   
3B2 28 12 Pull-up at D5. 
3B3 28 12   
3C1 28 12   
3C2 28 12   
3C3 28 12 Elevated baseline at Amel. 
3D1 28 12   
3D2 28 12   
3D3 28 12   
3E1 28 12 Pull-up at D5. 
3E2 28 12   
3E3 28 12   






# of Peaks # of HZ Loci over 50% Notes 
3F1 28 12   
3F2 28 12   
3F3 28 12   
3G1 28 12   
3G2 28 12   
3G3 28 12   
3H1 28 12   
3H2 28 12   
3H3 28 12   
3I1 28 12   
3I2 28 12   
3I3 28 12 Elevated baseline at D5. 
3J1 28 12   
3J2 28 12   
3J3 28 12   
3K1 28 12 Stutter at D3. 
3K2 28 12   
3K2A 28 12 
Multiple artifacts in various loci due to excess DNA in 
the sample. 
3K3 28 12   
3L1 28 12   
3L2 28 12 Pull-up at D5. 
3L3 28 12   
3M1 28 12   
3M2 28 12   
3M3 28 12   
3N1 28 12   
3N2 28 12   
3N3 28 12   
3O1 28 12 Pull-up at D5. 
3O2 28 12   
3O3 28 12   
3P1 28 12   
3P2 28 12   
3P3 28 12   
3Q1 28 12   
3Q2 28 12   
3Q3 28 12   
3R1 28 12   






# of Peaks # of HZ Loci over 50% Notes 
3R2 28 12   
3R3 28 12   
3S1 28 12   
3S2 28 12   
3S3 28 12   
3T1 28 12   
3T2 28 12   
3T3 28 12   
3U1 21 5 
D7: 41%, D16: 49%, drop-out at D2, D18, Amel, D5, 
and FGA. 
3U2 26 10 D7: 43%, FGA drop-out 
3U3 22 6 
D13: 30%, D16: 48%, drop-out at vWA, Amel, D5, 
and FGA. 
3V1 17 5 Drop-out at D7, D2, D19, vWA, D18, D5, and FGA. 
3V2 24 8 Drop-out at D3, D18, D5, and FGA. 
3V3 18 4 
Drop-out at D7, D13, D19, vWA, D18, Amel, D5, and 
FGA. 
3W1 25 9 Drop-out at D7, Amel, and D5. 
3W2 23 8 Drop-out at D7, Amel, D5 and FGA. 
3W3 26 9 D16: 35%, drop-out at D5 and FGA. 
3X1 27 11 D3: 37%, drop-out at D18. 
3X2 19 4 
D16: 49%, drop-out at D7, D2, vWA, D18, Amel, D5, 
and FGA. 
3X3 21 6 Drop-out at D7, D16, D2, D18, D5, and FGA. 
3Y1 22 6 D3: 30%, drop-out at D13, D2, D18, D5, and FGA. 
3Y2 21 6 Drop-out at D13, D2, D18, Amel, D5, and FGA. 
3Y3 25 7 D3: 49%, D16: 48%, drop-out at D7, D18, and D5. 
RB3A 0 0   
RB3B 0 0   
RB3C 0 0   
 
Sample Set 4 
Sample 
Name 
# of Peaks # of HZ Loci over 50% Notes 
4A1 28 12   
4A2 28 12   
4A3 28 12   
4B1 28 12   
4B2 28 12 Pull-up at TPOX and D5. 






# of Peaks # of HZ Loci over 50% Notes 
4B3 28 12   
4C1 28 12   
4C2 28 12   
4C3 28 12   
4D1 28 12   
4D2 28 12   
4D3 28 12   
4E1 28 12 Pull-up at TPOX, D18, and D5. 
4E2 28 12   
4E3 28 12   
4F1 28 12   
4F2 28 12   
4F3 28 12   
4G1 28 12   
4G2 28 12   
4G3 28 12 Pull-up at Amel and D5. 
4H1 28 12 Artifact present in multiple channels at ~278 bp. 
4H2 28 12   
4H3 28 12   
4I1 28 12 
Various artifacts and bad peak shapes due to bad 
injection. 
4I2 28 12   
4I3 28 12   
4J1 28 12 Pull-up at D5. 
4J2 28 12   
4J3 28 12   
4K1 28 12   
4K2 28 12   
4K3 28 12   
4L1 28 12   
4L2 28 12   
4L3 28 12 Pull-up at Amel and D5. 
4M1 28 12   
4M2 28 12   
4M3 28 12   
4N1 28 12   
4N2 28 12   
4N3 28 12   
4O1 28 12   






# of Peaks # of HZ Loci over 50% Notes 
4O2 28 12 Pull-up at D18. 
4O3 28 12   
4P1 0 0   
4P2 0 0   
4P3 0 0 Incorrect allele called at FGA (353 RFU). Artifact? 
4Q1 28 12 Elevated stutter at D3. 
4Q2 28 11 D7: 34% 
4Q3 28 11 D7: 48% 
4R1 28 12   
4R2 28 12   
4R3 28 12   
4S1 28 12   
4S2 28 12 Elevated stutter at D3. 
4S3 28 12   
4T1 28 12   
4T2 28 12   
4T3 28 12   
4U1 4 0 Drop-out everywhere except D8 and CSF1PO. 
4U2 0 0   
4U3 0 0 Artifact visible in blue and red channels. 
4V1 19 7 Drop-out at D7, D13, D2, D18, and FGA 
4V2 17 6 Drop-out at D7, D13, D18, Amel, D5 and FGA 
4V3 19 7 Drop-out at D7, D13, D18, D5, and FGA. 
4W1 28 12   
4W2 28 12   
4W3 28 10 D18: 43%, FGA: 49% 
4X1 28 10 D16: 47%, D18: 48% 
4X2 28 10 D13: 44%, FGA: 40% 
4X3 28 12   
4Y1 28 12   
4Y2 28 12   
4Y3 28 10 TH01: 42%, D19: 43% 
RB4A 0 0   
RB4B 0 0   
RB4C 0 0   
 
